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NAME = NG-nitro-L-arginine methyl ester
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NMDA = N-methyl-D-aspartate
NO = nitric oxide
NOS = nitric oxide synthase
NPY = neuropeptide Y
SEM = standard error of the mean
SNAP = S-nitroso-N-acetylpenicillamine
8-THEO = 8-(p-sulfophenyl)theophylline
VIP = vasoactive intestinal peptide
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THE COUPLING OF REGIONAL CEREBRAL BLOOD FLOW TO NEURONAL
ACTIVITY IS IN PART MEDIATED BY NITRIC OXIDE AND ADENOSINE.
Michael G. Kaiser*, Matthew J. During. Section of Neurosurgery, Department
of Surgery, Yale University, School of Medicine, New Haven, CT.
The coupling of regional cerebral blood flow to neuronal activity is
supported through a multitude of studies, however the factors responsible
remain unidentified. In the present study we investigated whether nitric
oxide and adenosine are involved in this coupling. Rats underwent
unilateral placement of both a microdialysis and laser doppler probe into the
CA1/dentate hilus of the hippocampus. Regional blood flow changes were
recorded with the laser doppler and represented as percent of baseline.
Microdialysis was used to deliver pharmacological agents and analyze the
interstitial fluid for adenosine and citrulline release, an index of nitric oxide
synthesis. The first group receiving increasing doses of NMDA (n=10),
responded in a dose dependent manner with increases of 106.8+2.3%,
120.0+6.3%, 148.0±16.6%, 191.4+20.4% at 50, 100, 200, and 500 pM NMDA.
Both citrulline and adenosine demonstrated significant increases from
baseline. Animals receiving a direct nitric oxide donor (n=6), demonstrated
increases of regional blood flow to 137.0+5.8%. Inhibition of nitric oxide
synthase, with NG-nitro-L-arginine methyl ester, decreased basal flow to
77.0+3.0% of baseline (n=9), and attenuated the response of 200 pM NMDA
from 164.0+17.4% to 125.0+6.5% of baseline (n=7). The effects of this inhibitor
were significantly reduced by simultaneous infusion L-arginine (n=6). Basal
and NMDA induced citrulline release were significantly decreased with NGnitro- L-arginine methyl ester . The adenosine receptor antagonist, 8-(p-sulfophenyl) theophylline, also decreased both basal blood flow and the response
to 200 pM NMDA (n=5). Preliminary results indicate that stimulation of the

/

perforant pathway increases cerebral blood flow in the hippocampus (n=2).
Studies are presently underway to characterize the mediators of this response.
Based on these results nitric oxide and adenosine participate in the coupling
of regional hippocampal blood flow to neuronal activation.
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INTRODUCTION
A. Opening Remarks
"The chemical products of cerebral metabolism contained in the
lymph which bathes the walls of the arterioles of the brain can cause
variations of the calibre of the cerebral vessels. In this reaction the
brain possesses an intrinsic mechanism by which its vascular supply
can be varied locally in correspondence with local variations of
functional activity."

-Roy and Sherrington 1890

This statement is generally considered the foundation for research
which investigates the coupling of regional cerebral blood flow (rCBF) to
neuronal activity. This postulate was truly ahead of its time, especially since
the ability to quantitatively measure and demonstrate definitive changes in
rCBF was not developed until the early 1950's. Since then a multitude of
studies have demonstrated this relationship, however the "intrinsic
mechanism" alluded to by Roy and Sherrington, responsible for this
coupling, remains to be identified. Factors which have been considered
include locally released products of metabolism, decreased tissue p02,
potassium ions released with neuronal depolarization, and
neurotransmitters. All of these substances were in vogue at one time or
another and shown to alter rCBF, however convincing evidence identifying
them as the direct link between rCBF and neuronal activity is lacking.
Progress in resolving this issue was only possible with advancements
in the techniques which monitor rCBF. Over the years these new methods
have not only simplified measurements, but also improved the temporal and
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spatial resolution. Such techniques have demonstrated an instantaneous
increase in rCBF within the specific vascular bed supplying an individual
group of neurons. Unfortunately what the previous studies lacked was the
ability to observe mediators released in the extracellular fluid while changes
in rCBF were being measured. To truly gain an understanding of this
relationship, such a method must be developed which would allow mediator
release to be correlated with increases in rCBF during neuronal activation.

B. Development of a Suitable Method
Throughout most of the 1800's cerebral blood flow (CBF) was generally
thought to be constant (ladecola 1993). This assumption was derived from the
Monro-Kellie Doctrine, formulated in 1783, which in part states, "...quantity
of blood within the head must be the same, or very nearly the same, at all
times , whether in health or disease, in life or after death...," and was based on
the rigid nature of the skull and the inability of the brain to undergo
significant compression. Since no methods to monitor CBF were available at
this time, the hypothesis went unchallenged. Even as late as 1936 significant
uncertainty remained. After reviewing the available literature, HG Wolff
came to the conclusion that knowledge on CBF was deficient, "Unfortunately,
the amount of blood going to the brain still remains an uncertain quantity,"
(Wolff 1936).
Prior to this date quantitative measures of CBF were attempted by
observing the perfusion through cerebral vessels of excised brains. These
studies were clearly far from ideal and involved enormous errors. In 1943
Dumke and Schmidt provided some of the first reliable quantifications of
CBF by timing the passage of an injected air bubble through a flowmeter
which contained blood diverted from the cerebral circulation, the bubble
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flowmeter. Although still producing non-physiological measurements, it
was considered "less abnormal" than the previous methods (Dumke and
Schmidt 1943). The first quantitative measurements of human CBF were
made in 1945 using inhalation of nitrous oxide gas. The method is based on
the Fick equation of continuity which determines blood flow through an
organ by dividing the organ's consumption of a particular substance by the
arterio-venous concentration difference of that substance. This came to be
known as the Kety-Schmidt method (Kety and Schmidt 1945; Kety and
Schmidt 1948). It became the standard for CBF measurements over the next
decade, modified by using different tracer substances, such as ^Krypton
which increased technical accuracy (Lassen and Munck 1955). Another
technique available at this time was the indicator-dilution method. Either
dye or radioactively labeled erythrocytes were injected into the arterial
cerebral circulation and dilution of the tracer was observed by repeated
sampling of the jugular venous blood. The sample concentrations were
plotted over time, producing a dilution curve. CBF was determined through
mathematical computations involving the area under the dilution curve
(Nylin and Blomer 1955). Although both of these techniques possessed
inherent limitations, the inability to distinguish blood flow within various
segments of the brain, the inability to measure rCBF, was the most significant.
Qualitative observations of rCBF had been made since the 1920's by
direct visualization of pial vessels (Florey 1925), counting tissue capillaries
(Cobb and Talbott 1927), and locally implanted thermoelectric devices (Gibbs
1933). Not until 1958, with the advancement of autoradiographic techniques
was a method available which demonstrated quantitative differences in flow
between various macrostructures of the brain. This technique, similar to the
Kety-Schmidt method, is also based on the Fick principle. CBF is determined
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by the exchange of a biologically inert tracer between the blood and the tissue.
After administration of a radioactive tracer, flow per unit weight of tissue is
computed by determining the change in arterial concentration of the tracer
over a specified time period, the tissue:blood partition coefficient, and the
concentration of tracer in the specific brain locus. The tissue concentration is
determined from the optical density produced on a radiograph (Freygang and
Sokoloff 1958). This method however, still failed to demonstrate flow within
specific microcirculatory beds. More important was the inability to make
repeated observations since each measurement required sacrificing the
subject. This not only made continuous monitoring impossible but also
precluded such a method from human investigations. Development of
additional techniques continued throughout the 1960's and include the
radioisotope clearance method, the hydrogen clearance method, and the
radiolabeled microsphere technique.
The radiolabeled microsphere technique resembles previous auto¬
radiographic methods for determining local blood flow. Instead of an inert
gas, carbon microspheres are used as the radioactive tracer. The optical
density on the radiographs depends on the amount of microspheres which
become trapped in the tissue capillaries. This method is valid only under the
assumptions that the microspheres are too large to pass through the
capillaries of the tissue, the particles mix uniformly within the blood stream,
and they are not metabolized (Roth et al 1970). Important limitations include
the inability to produce more than one measurement per subject, the use of a
radioactive substance, the need for repeated blood sampling, and variability
secondary to non-random distribution of microspheres from inadequate
mixing and recirculation (Buckberg et al 1971).
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The hydrogen clearance method determines flow based on the current
produced by hydrogen delivery to an implanted probe. Hydrogen gas inspired
by the subject equilibrates in the tissues and produces current in proportion to
its concentration. The inspiration of hydrogen is then stopped and the
concentration decreases at the tissue site as the gas is removed by the local
blood flow. This decrease in the concentration of hydrogen causes the current
to decrease. The rCBF is determined from the curve of the decreasing current
(Haining et al 1968). Limitations of this method include tissue trauma
produced by probe implantation, variability due to diffusion of hydrogen into
the tissues, inability to follow rapid changes in rCBF, and complex data
analysis and interpretation (Skarphedinsson et al 1988, Halsey et al 1977,
Lacombe et al 1980).
Radioisotope clearance methods determine flow by observing the
decrease in radioactivity of various brain regions over time. A diffusable
radioactive tracer is injected, or inhaled, and enters the tissue blood stream.
This tracer then diffuses across the endothelium and is taken up by the tissue.
The radioactivity is then measured with extracranial detectors. The rate of
clearance of the tracer depends on the blood flow to the area in question
(Ingvar and Lassen 1962) This method however requires radioactive
substances, has a poor spatial resolution due to extracranial detection, and
requires complex data analysis with instability of results due to tracer
recirculation and diffusion (Holti and Mitchell 1978; Holloway 1980). An
improvement in spatial resolution was achieved by coupling this technique
to CT imaging (Drayer et al 1978), but this modification resulted in new
sources of error (Good et al 1982).
Although the hydrogen clearance and radioisotope washout methods
allow repeated measurements for each subject, they are still unable to make
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continuous recordings and demonstrate instantaneous changes in blood flow.
Such an ability could correlate rapid changes in rCBF with release of putative
mediators. Recent developments in non-invasive imaging techniques, such
as functional magnetic resonance imaging which monitor flow based on
deoxyhemoglobin tissue content, has a time resolution of less than two
seconds, the ability for repeated measurements, and a spatial resolution as
small as 4-6 mm (Schulman et al 1993). These techniques however are still in
development, require great expense, and have a very limited availability.
Over the last twenty years one technique has been developed which
has significant advantages over the existing methods This technique is
known as laser doppler flowmetry (LDF) (Stern 1975). LDF is based on the
frequency shift that occurs to laser light when it is reflected off a moving
object, the Doppler effect. The laser light is emitted into a tissue through a
fiber optic guide. This light penetrates thin walled vessels, such as small
arterioles, venules, and capillaries. The light is randomly reflected by blood
cells, those in motion will produce a frequency shift in the light. Some of this
reflected light is returned to the probe and consists of both unshifted and
Doppler shifted frequencies. The laser doppler unit determines rCBF from
the differences in these frequencies. Since the majority of moving cells
reflecting the light are red blood cells, the value obtained is a measure of their
flow. A detailed description of the principles behind LDF are discussed in
Appendix IA. The major advantages of LDF over existing techniques include
the ability to make continuous measurements of blood flow (Oeberg et al
1984), a spatial resolution within 2mm3 (Eyre et al 1988), a temporal
resolution within the millisecond range (Lindauer et al 1993), and LDF does
not require invasive manipulations (Oeberg et a 1984). Initially the
technique's major application was measurements of the skin
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microcirculation (Allen and Goldman 1987; Braverman 1990), however its
value in measuring rCBF has quickly been recognized (Eyre et al. 1988;
Dirnagl et al. 1989; Haberl et al. 1989, and Lindauer et al 1993). As with other
techniques there are limitations with LDF. The primary disadvantage is the
inability to quantify blood flow in terms of volume per time. Therefore data
from LDF must be represented as percent changes in rCBF (Dirnagl et al 1989).
Other minor limitations, including a high sensitivity to movement artifact,
can be overcome with carefully controlled experimental conditions.
Although LDF is able to reflect instantaneous changes in rCBF with increased
neuronal activity, it does not possess any intrinsic ability to identify possible
mediators released in the extracellular fluid. To investigate the factors
responsible for the coupling of rCBF to activity, an additional technique is
needed to meet this requirement.
Over the years a number of techniques have been developed which
allow the determination of substances within the brain interstitial fluid.
These can be divided into those which make in situ measurements and those
which require ex situ analysis. The in situ methods include ion-selective
microelectrodes which are able to only identify ions (Thomas 1978), and
carbon fiber microelectrodes which only detect oxidizable substances
(Marsden et al 1984). Major limitations are associated with each method.
Carbon microelectrodes have a reduced selectivity when measuring
substances with similar oxidation potentials, both methods consume the
species being measured, and both have a short working life in vivo
(Benveniste 1989). The ex situ methods include the cortical cup (Dodd and
Bradford 1974), the push-pull cannula (Pillippu 1984) and brain microdialysis
(Bito et al 1966; Delgado et al 1972; and Ungerstedt 1984). The former two
techniques have a poor temporal resolution (>10 minutes), the cortical cup
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can only measure cortical fluid, push-pull cannulae produce a significant
amount of tissue trauma, samples obtained from both methods require
deproteinization prior to analysis by high pressure liquid chromatography
(HPLC), and considerable amount of enzyme degradation within samples can
occur before measurements are made (Benveniste 1989). Microdialysis is an
established method to evaluate the extracellular environment, and has
arguably become the standard technique for in vivo neurochemical
measurements (Robinson and Justice 1991). In principle microdialysis can
collect virtually any substance in any area of the brain with minimal tissue
trauma. The theory behind microdialysis is based on the simple diffusion of
substances down their concentration gradients. An artificial fluid, lacking the
substance to be measured, is passed through the microdialysis probe. As a
tissue releases the substance it will diffuse across the permeable microdialysis
membrane and enter the artificial fluid within the probe. This fluid is
continuously pumped through the probe, collected at an outlet, and analyzed
by techniques such as HPLC (Benveniste 1989). A detailed description of the
mechanics can be found in Appendix A. A major advantage of microdialysis
is the ability to not only sample the extracellular fluid but also to deliver
pharmacological agents to the local parenchyma without producing systemic
effects. This allows the activity of a specific group of neurons to be
manipulated, avoiding the release of mediators from other peripheral tissues,
such as endothelial cells, which may alter blood flow. As with all
experimental techniques there are disadvantages to microdialysis. Obtaining
the actual concentration of a substance within the extracellular fluid requires
complex data interpretation that is based on assumptions which are not
necessarily valid. Results are therefore generally represented as percent
changes from baseline values. Also the probes are extremely delicate and can
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easily break if not handled properly. In spite of these limitations, the
combination of both laser doppler flowmetry with brain microdialysis should
prove to be a powerful tool in the investigation of the coupling of rCBF to
neuronal activity.

C. Regulation of CBF
The regulation of cerebral perfusion occurs at two separate levels. One
level determines the overall perfusion of the brain, designated as mean
cerebral blood flow (mCBF). The second distributes blood to specific neuronal
groups during increased activity, known as rCBF. Since in essence rCBF
ultimately depends on mCBF, and regulatory mechanisms may be shared
between the two, it is important to first obtain an understanding of mCBF
regulation.

i. Regulation of mCBF
Prior to monitoring mCBF it was known that arterial pressure was the
driving force for the cerebral circulation, however the question of whether
the brain had the intrinsic power to change mCBF was unanswered (Hill and
MacLeod 1900). With the ability to quantitate mCBF, studies demonstrated
changes in this flow and factors other than systemic pressure which could
alter it. In 1943 Dumke and Schmidt, using the bubble flowmeter in
monkeys, demonstrated increases in mCBF with anoxemia and hypercapnia,
while decreased mCBF occurred with hyperoxia (Dumke and Schmidt 1943).
This was one of the first studies which demonstrated an intrinsic control of
cerebral vascular tone. Kety and Schmidt describe not only their method to
measure mCBF but also the effects of increased intracranial pressure (ICP),
hyperventilation, and changes in arterial tensions of CO2 and O2. In a study
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to determine the effects of hyperventilation on military pilots, Kety and
Schmidt demonstrated a reduction of 33%-35% in mCBF with
hyperventilation (Kety and Schmidt 1946). Using patients with known
intracranial tumors, increased ICP was associated with an increase in cerebral
vascular resistance and an eventual reduction in mCBF (Kety and Schmidt
1948). Increases in mCBF of 75% and 35% were reported during inhalation of
5%-7% CO2 and 10% O2 respectively. Increasing the concentration of inhaled
O2 to 85%-100% decreased mCBF by 13% (Kety and Schmidt 1948). Even
though these substances were shown to affect mCBF it was still believed in
1950 that mCBF fluctuated freely with systemic blood pressure (Schmidt 1950).
In 1964 an autoregulatory response in canine mCBF was demonstrated. Its
control was mediated by the release of the metabolic factors which had
previously been shown to alter mCBF, including CO2, H+, and O2. It was also
proposed that these factors could inhibit the autoregulatory response through
excessive vasodilatation (Rapela and Green 1964). In 1968 Plum and Posner
demonstrated this inhibition with a global increase in tissue CO2 production
during induced seizures. A reported increase of 264% in mCBF occurred with
a 72 mm Hg increase in systemic blood pressure. This increase was attributed
to the loss of autoregulation and passive response of mCBF to arterial blood
pressure (Plum et al 1968). These and other studies have demonstrated the
principles which govern regulation of mCBF.
Consistent delivery of blood to the brain is extremely important. The
brain, while only 2% of body weight, requires 15% of the total cardiac output
and 20% of total body oxygen consumption. These requirements demonstrate
how dependent the brain is on oxidative metabolism, without a significant
reserve for glycolysis (Chien 1985). The main determinants of mCBF include
arterial pressure, blood viscosity, and cerebral vascular resistance. Arterial
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pressure is mainly determined from the cardiac output and systemic
resistance, while blood viscosity is mainly a function of hematocrit. Cerebral
arterial resistance is primarily determined by the radius of the vessel, since
resistance is proportional to the fourth power of the radius. Factors which
control the tone of the large cerebral vessels therefore have a profound effect
on mCBF. These factors include the rigid cranium housing the brain,
neuronal innervation, and autoregulation (Chien 1985; Guyton 1986).
Although original assumptions of mCBF based on the Monro-Kellie
doctrine were incorrect, its principles are a determinant of extraparenchymal
vascular resistance. ICP is produced by the four major components within
the cranium; blood, cerebrospinal fluid, interstitial fluid, and brain tissue.
Volume increases of one must be compensated by decreases in the others.
Small fluctuations in ICP occur under normal physiological conditions, such
as respiration. These changes do not produce harmful sequelae, mainly
through the ability of the venous sinuses to undergo compression.
Intracerebral arteries are able to resist such small increases in ICP by reducing
the active tension in the vessel wall through smooth muscle relaxation
(Chien 1985). Excessive relaxation however will lead to stretching of
neighboring dural structures and produce pain. This is thought to be one
etiologic agents of a headache (Martin 1991). The effects of an elevated ICP on
mCBF are more pronounced under pathological conditions. For instance,
large increases in ICP may produce displacement of brain tissue, known as
herniation, and compress vessels leading to total disruption of blood flow
(Morris and Phil 1989).
Another contributor to the regulation of mCBF is neuronal innerva¬
tion of large extraparenchymal vessels. These neurons are derived from a
number of cranial nerve ganglia and contain a multitude of neuro-
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transmitters. Their precise function remains to be determined. Projections
from the ophthalmic division of the trigeminal nerve, via the nasociliary
nerve, have been shown to innervate the vessels making up the Circle of
Willis and portions of the basilar artery (Keller et al 1985; Suzuki et al 1989).
Neurotransmitters identified within these fibers include substance P,
calcitonin gene-related peptide (CGRP), and galanin The function of these
fibers is presumably sensory (Edvinsson 1985; Owman et al 1989; Suzuki et al
1989). Sympathetic fibers originating from the superior cervical ganglion and
stellate ganglion innervate these same vessels as well as smaller pial arteries
and arterioles. The terminals contain not only norepinephrine (NE), but also
neuropeptide Y (NPY) (Lou et al 1987; Edvinsson et al 1989). Stimulation
produces cerebral vasoconstriction, however this effect is weak compared to
systemic sympathetic vasoconstriction (Chien 1985). A third group of fibers,
originating from the sphenopalatine ganglion contains enzymes capable of
producing acetylcholine (ACh), nitric oxide (NO), and vasoactive intestinal
peptide (VIP) (Nozaki et al 1993; Edvinsson et al 1972). Other sources of ACh
containing neurons include the otic ganglia, the dorsal root ganglion at C2,
and microganglia of large vessels (Gibbons et al 1984; Edvinsson et al 1989).
Stimulation of these fibers, from the sphenopalatine and otic ganglia, have
demonstrated significant increases in cortical blood flow independent of
cerebral metabolic rate (Goadsby 1989). Although it is clear that the pathways
originating from the various cranial ganglia affect mCBF, their exact role is
yet unknown. There is evidence suggesting that these fibers may have a
protective effect under pathologic states such as hypertension, ischemia, or
seizures (Chien 1985; Koketsu et al 1992; Sakas et al 1989), and that they
deliver trophic factors to the vasculature (Aubineau et al 1989; Dimitriadou et
al 1989).
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By far the most important mechanism regulating mCBF is auto¬
regulation, i.e. the intrinsic ability of an organ to stabilize its perfusion with
changes in systemic pressure and to adjust perfusion based on metabolic
demands. Changes in the caliber of vessels are produced by the products of
metabolism, including pCC>2, pC>2, extracellular H+, and adenosine.
Vasodilatation occurs with an increase in pCC>2 and adenosine, and a decrease
in pC>2 and interstitial pH. Vasoconstriction occurs under the opposite
conditions. The most important of these factors is pCC>2, producing its effect
mainly by decreasing extracellular pH (Kontos et al 1977). The hydrogen ion
concentration is extremely important since an increase can lead to a number
of destructive processes altering neuronal function, including myelin
breakdown and disruption of interaxonal connections, as well as irreversible
damage of both glia and neurons (Goldman et al 1989). A build up of
metabolites occurs with inadequate perfusion, produces an increase in flow,
and results in increased nutrient delivery and waste removal. Despite
variations in systemic pressure, a constant cerebral perfusion is maintained
through two possible mechanisms, one involving vasoactive metabolites and
the other vessel wall tension. When arterial pressure increases, an initial rise
in mCBF removes metabolites at a faster rate. This will result in a
vasoconstriction and return of flow to previous levels. When arterial
pressure falls these metabolites are allowed to build up producing
vasodilatation, and flow increases (Chien 1985; Guyton 1986). The second
mechanism involves changes in vessel wall stretch, which are determined by
transmural pressure. When pressure increases the elastic elements of arterial
walls will stretch and produce a reflex contraction. The action of smooth
muscle cells will increase the active tension and maintain a stable vascular
resistance. With low pressure the amount of stretch decreases, the elastic
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elements relax, and the smooth muscle cells also relax. This is known as the
myogenic reflex. At present it is unknown which of these two mechanisms
predominates in autoregulation, however both are likely to be involved
(Guyton 1986).
The factors determining mCBF insure that the delivery of nutrients
meets the brain's high metabolic requirements, and excessive flow is avoided.
These mechanisms control the large volume of blood delivered to the brain,
however both metabolic factors and neuronal innervation have also been
implicated as agents coupling the small volume changes associated with the
coupling of rCBF to neuronal activity.

ii. Regulation of rCBF
While the mechanisms regulating mCBF are suited to determine the
perfusion of the brain as a single entity, there are two factors which
necessitate a more precise control at the level of functional neuron groups.
Neurons have virtually no capacity for anaerobic metabolism and contain
very limited fuel reserves (Morris and Phil 1989; Plum 1983). In order to
increase activity there must be an increase in the delivery of nutrients. In
addition, given the heterogeneity of activity in the brain, it is essential that
there be a form of regulation allowing local groups of neurons to increase
their specific blood supply without affecting the blood flow to other regions.
This type of regulation was postulated by Roy and Sherrington over one
hundred years ago.
Utilizing the methods previously described the existence of a
relationship between rCBF and neuronal activity has been demonstrated
through a multitude of studies. Using autoradiographic techniques, retinal
stimulation of a cat's eye was shown to produce increases in blood flow to
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specific regions of the central visual pathways (Sokoloff 1961). A
heterogeneous change in human cortical blood flow was demonstrated using
the 133xenon washout method during a motor task. Individuals were
motivated to open and close one hand while the contralateral cerebral
hemisphere was monitored for blood flow changes. A 54% mean increase in
the contralateral hemisphere was observed in nine out of ten subjects. In all,
the hand area within the motor cortex was identified (Olesen 1971). In 1980
Roland was able to uncover the role of the supplemental motor cortex in
motor task initiation by observing changes in rCBF. Subjects were asked to
mentally rehearse a task but not carry it out. Increases in rCBF were observed
to occur only in the supplemental motor cortex (Roland et al 1980).
Advancement of autoradiographic techniques which correlate glucose
utilization with cerebral activity, the [l^Q-deoxyglucose method (Sokoloff
1977), definitively established the relationship between local cerebral activity,
energy metabolism, and rCBF. Combined with [l^cj-iodoantipyrine method
to measure blood flow (Sakurada et al 1978), identical areas of increased
metabolism and rCBF were demonstrated during focal seizures in the
monkey motor cortex (Sokoloff 1981). Studies have also shown the opposite
effects on metabolism and rCBF with decreases in functional activity. Visual
deprivation of rats, produced by enucleation of one eye, resulted in unilateral
decreases in both energy metabolism and rCBF in the lateral geniculate body,
superior colliculus, and visual cortex, areas of expected decreased activity
(Sokoloff 1981).
The specificity of the increased rCBF response has also been
demonstrated. Using autoradiographic techniques the increase in rCBF
during rat whisker vibrissal stimulation was limited to a cylinder of tissue
from 375 pm to 500 pm in diameter (Greenberg et al 1979). The types of
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vessels affected include the intraparenchymal vessels and the upstream
resistance vessels supplying them. Excluded from the response were the
parent vessels which distribute blood to additional areas (Ngai et al 1988).
These are just a few of the studies which have convincingly
demonstrated that increased activity of discrete neuronal populations can
specifically alter their own blood flow. What remains to be identified are the
mechanisms of this coupling. Roy and Sherrington originally proposed that
chemical products of metabolism would diffuse in the interstitial fluid and
produce vasodilatation. In particular they implicated the acidic products of
metabolism. Since that time this group has grown to include the molecules
CO2 and adenosine.
With direct application of CO2 to cat cortex, pial vessels were shown to
dilate. Antagonism of the dilatation was produced with the addition of
acetazolamide, a carbonic anhydrase inhibitor. This enzyme is responsible for
the formation of carbonic acid from CO2 and H2O. Thus the results from this
study indicate that decreasing pH will promote vasodilatation (Gotoh et al
1961). The opposite effect was identified in patients with organic dementia.
These individuals had a reduction in mCBF of 25%-30% which correlated
with a significant increase in the interstitial pH when compared to normal
controls (Skinhoj 1966). Formation of organic acids, such as the development
of lactic acidosis during tissue hypoxia, also produces an increases in rCBF
(Kogure et al 1970). The effects of a decreased interstitial pH are confined to
the perivascular space since intravascular injection of a low pH solution does
not produce a change in flow unless the blood brain barrier is traversed
(Lassen 1966). These are just a few of the earlier studies demonstrating the
local vasodilatation produced by decreasing pH.

24

A decrease in interstitial pH is endogenously produced through two
separate metabolic pathways. The first is direct release of lactic acid during
anaerobic glycolysis. The second is the conversion of C02, released from the
citric acid cycle, into carbonic acid by the enzyme carbonic anhydrase. Since
neurons rely so heavily on oxidative phosphorylation, CO2 is the main
mechanism of decreasing extracellular pH (Gotoh et al 1961; Kontos 1977).
How an increase in the extracellular concentration of H+ produces
vasodilatation is unknown, but it is thought to occur by blocking the Ca+2
conductance of vascular smooth muscle (Silverberg 1989). More recent
evidence also suggests that CO2 may have the ability to increase rCBF
independent of pH (Aubineau et al 1989).
Although a decrease in extracellular pH is known to alter rCBF, there is
substantial evidence which indicates that this is not the only factor
responsible and that it cannot initiate the increase of rCBF to neuronal
activation. In certain instances of seizure and hypoxia an increase in rCBF
occurs without a change and occasionally an increase in extracellular pH
(Astrup et al 1978). More significant are studies which compare the timing of
increased rCBF with decreases in extracellular pH. Increases in rCBF occur
immediately with increased activity, yet a significant time delay of five to ten
seconds occurs before a decrease in extracellular pH is observed (LenigerFollert 1984). Due to this time difference, the decrease in extracellular pH
could not act as the primary coupling agent between neuronal activity and
rCBF. This does not mean that extracellular pH is not involved with
increased rCBF during activity. It is clear that this decrease in pH will increase
rCBF, but the effect is more likely to be ancillary, helping to maintain flow
during periods of sustained activity.
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Tissue oxygen levels, specifically the decrease associated with increased
metabolism, have also been suggested as a coupling agent. Earlier studies
hypothesized an initial tissue hypoxia occurring during the onset of neuronal
activity would produce vasodilatation (Ingvar et al 1962; Caspers and
Speckmann 1972). What many of these studies failed to do was to separate
the effect of the decreased tissue oxygen from the production of other
vasodilating metabolites. Recent investigations do not support these earlier
assumptions and actually demonstrate an increase in tissue pC>2 at the onset
of increased activity (Silver 1978; Leniger-Follert and Lubbers 1976; LenigerFollert 1984). Advancement of magnetic resonance imaging techniques,
which monitor tissue levels of deoxyhemoglobin, have also demonstrated a
hyperoxia during increased neuronal activity (Ogawa et al 1992; Shulman et al
1993). Based on these studies it would seem that there is no initial hypoxia
produced, and in fact an immediate excess of available oxygen occurs with
increased activity.
Adenosine's role is more complex than the other products of
metabolism, since adenosine may also produce vasodilatation as a
neurotransmitter. Adenosine is known to produce vasodilatation in a
number of vascular beds, including the cerebral circulation (Burnstock 1990;
Morii et al 1986; and Ibayashi et al 1991). This vasodilatation is mediated by
binding to the surface P2 purinergic receptor (Burnstock 1990; Olsson and
Pearson 1990; Ngai and Winn 1993). This receptor complex is coupled to a
GTP binding protein (Torregrosa et al 1990; Hardebo et al 1987), which
activates phospholipase C and increases intracellular concentrations of
inositol 1,4,5-triphosphate and Ca+2 (Forsberg et al 1987; Brock et al 1988;
Carter et al 1989). Such receptors have been identified throughout the
cerebral vascular tree (Edvinsson and Fredholm 1983; Hardebo et al 1987;
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Ibayashi et al 1991). Their action has been localized to the extraluminal side of
cerebral vessels indicating that the mechanism of adenosine vasodilatation is
endothelium independent (Ngai and Winn 1993).
The exact role adenosine plays in the coupling of rCBF to neuronal
activity is controversial. During bicuculline induced seizures both rCBF and
adenosine concentrations have been shown to increase (Winn et al 1980).
Studies using adenosine deaminase, an antagonist of the adenosine mediated
vasodilatation, have shown conflicting results. A heightened response of
rCBF to anoxia has been shown with adenosine deaminase inhibitors (Phillis
et al 1985), however direct application of adenosine deaminase did not block
the response of rCBF with hypoxia or electrical stimulation (Dora et al 1980).
With sciatic nerve stimulation the response of rCBF in the somatosensory
cortex has been manipulated by substances which affect adenosine availability
(Ko et al 1990), however application of 8-(p-sulfophenyl) theophylline
(8-THEO), an antagonist of purinergic receptors, did not attenuate the increase
in rCBF (Northington et al 1992). During brain ischemia adenosine increases
by two fold within five seconds (Winn et al 1985), however this concentration
increase has only a marginal affect on pial vascular resistance (Wahl and
Kuschinsky 1977). These conflicting results do not remove adenosine as a
possible agent in this coupling, but instead demonstrate that other factors
must be involved.
Another consideration is the source of adenosine release. As stated
earlier adenosine can be released as a metabolic by-product and as a
neurotransmitter.

Dephosphorylation of adenosine monophosphate during

metabolism results in increased extracellular concentration of adenosine
(Rubio et al 1975). An important factor which supports adenosine's role as a
neurotransmitter instead of a product of metabolism is the time delay
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between build up of metabolic factors and increase in rCBF. Adenosine and
adenosine nucleotides have been identified in a number of nerve terminals
which innervate blood vessels (Burnstock 1990). Adenosine triphosphate
(ATP) has been localized in various neurons and is thought to act as a co¬
transmitter. The extracellular breakdown of ATP may serve as one source of
adenosine release (Richardson et al 1987; Pelleg and Burnstock 1990). In
addition adenosine is directly released from neurons during depolarization
(Phillis and Wu 1981; Bender et al 1981; Jonzon and Fredholm 1985; During
and Spencer 1992). As discussed below, neurotransmitters are the most likely
agents to couple rCBF to neuronal activity. Considering this evidence
adenosine is capable of acting as the coupling agent but at least one other
compound must be involved.
A final consideration which does not support the hypothesis that
metabolic factors are the direct link between rCBF and neuronal activity is
their disproportionate increases. This has been shown at the neuronal (Silver
1978) as well as regional level (Nilsson et al 1978). During periods of intense
activity, e.g. hyperthermia and status epilepticus, the increase in blood flow is
much greater than the metabolic requirements of activated tissue (Nilsson et
al 1978). This discrepancy is not limited to pathological conditions, but also
occurs with physiological activation. During finger vibration stimulation the
contralateral somatosensory cortex demonstrated an increase in rCBF of 29%
while there was only a 5% increase in the regional cerebral metabolic rate of
C>2 consumption (rCMRC>2). In addition a decline of 02 extraction of 20%
occurred. This discrepancy could not be explained by a transient overshoot of
rCBF or a time delay in the rCMRC>2 increase (Fox and Raichle 1986).
Based on the evidence presented, several assumptions can be made in
regards to the role which metabolic by-products may play in the coupling of
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rCBF to neuronal activity. (1) These agents cannot act as the sole factors
involved due to the discrepancy between rCBF and metabolic requirements.
(2) There must be additional factors which initiate the increase in rCBF given
the time difference between increased flow and the accumulation of
metabolic factors. (3) These agents do increase rCBF, but most likely act to
maintain it during sustained activity (Lou et al 1987).
Since the evidence for metabolic by-products as the regulatory agents of
rCBF is not convincing, other factors released during neuronal activation
have been implicated, such as K+. It is well established that during neuronal
activity the extracellular concentration of potassium increases due to changes
in the conductance characteristics of the neuronal membrane. K+ has also
been shown to act as a potent vasodilator (Kuschinsky et al 1972). It therefore
seemed likely that K+ could act as a link between the increase in rCBF and
neuronal activity. One problem with this hypothesis was that simple
diffusion could not distribute the ion in sufficient concentrations over the
area needed in the short time interval allowed. Astrocytes were hypothesized
to overcome these spatial and temporal obstacles. K+ ions released in the
extracellular environment during increased neuronal activity are taken up by
astrocytes. This uptake depolarizes the cell and causes a K+ efflux, resulting
in a spatial buffering (Barres et al 1990). The areas of the astrocyte which have
the greatest conductance for K+ are the astrocytic endfeet which are intimately
associated with intraparenchymal resistance vessels. Using a computer
simulation, this effect, known as "K+ siphoning," could produce a sufficient
concentration in the perivascular space in a shorter time period than simple
diffusion would accomplish (Paulson and Newman 1987). This hypothesis,
although very attractive, was not supported by direct experimental evidence.
Antagonism of astrocytic K+ uptake, with Ba+2, did not attenuate the increase
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in rCBF which occurs during electrical stimulation (Kraig and Iadecola 1989).
Other studies have also demonstrated increases of rCBF independent of K+.
Amphetamine stimulation produces an increase in rCBF without any change
in extracellular K+ (Berntman et al 1978). K+ ions may play a minor role in
increasing rCBF however it seems unlikely that K+ could produce the degree
of increased rCBF observed.
Given the evidence presented thus far, the mediators suggested, except
for adenosine, are unlikely to serve as the direct link between neuronal
activity and rCBF. Instead these compounds are more likely to play an
accessory role. Due to the spatial and temporal precision needed, direct
neuronal innervation appears to be the only means by which rCBF may be
coupled to neuronal activity. Extensive evidence exists which demonstrates
the intimate relationship between neuron terminals and intraparenchymal
vessels (Hartman et al 1972; Csillik et al 1971; Rennels and Nelson 1975)
Three types of neuronal innervation have been hypothesized which may
provide the necessary coupling agent in this response; fiber pathways
originating from extrinsic ganglia, fiber pathways originating from
intracerebral nuclei, and local neurons (Iadecola 1993).
The extrinsic pathways communicating with cerebral vessels have
previously been described in mCBF regulation. These fibers originate from
several extrinsic ganglia including the superior and stellate ganglia, the
trigeminal ganglion, and the sphenopalatine ganglion. They contain a wide
variety of neurotransmitters, previously described, which have vasomotor
effects. These pathways however are not likely to mediate the coupling
between neuronal activity and rCBF. The vessels which these fiber tracts
innervate are the large extraparenchymal vessels, which control CBF at a
gross level. Also studies in which these fiber bundles are interrupted have
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shown no change in the response of rCBF with local neuronal stimulation
(Ibayashi et al 1991; Iadecola et al 1993).
Intrinsic pathways contain many of the same neurotransmitters within
the fibers of the extrinsic pathways (Iadecola 1993). There are many studies as
well which demonstrate changes in CBF with stimulation of these pathways.
Intrinsic adrenergic fibers, from the locus coeruleus, innervate cerebral
vessels (Swanson et al 1977) and produce changes in microvessel permeability
and flow with chemical and electrical stimulation (Raichle et al 1976). Fibers
from the raphe nuclei, releasing 5-hydroxytryptamine (5-HT), innervate
cerebral microvessels and produce vasodilatation with stimulation
(Edvinsson et al 1983; Harper and MacKenzie 1977; Reinhard et al 1979).
Stimulation of cholinergic pathways, from the cerebellar fastigial nucleus
(Iadecola et al 1987; Nakai et al 1982) and basal forebrain (Arneric 1989),
produces a global increase in cortical flow. It is obvious that such pathways
can influence large areas of rCBF, however there is considerable evidence
which indicates that these pathways are not the main mechanism coupling
spatially discrete increases in rCBF. Lesions and pharmacological blockade of
the cholinergic fibers does not hamper the effect of somatosensory
stimulation on rCBF (Ibayashi et al 1991). Local release of VIP through
stimulation of the reticular formation and cortex may participate in local
cortical increases in blood flow, however a significant portion of this response
is independent of VIP (Yaksh et al 1987; Iadecola 1993). The locus coeruleus is
thought to affect rCBF responses to cortical stimulation through an effect on
oxidative metabolism (LaManna et al 1981; Iadecola 1993). Given this
information and the diffuse innervation of these intrinsic pathways, a more
likely mechanism of their action is to regulate mCBF instead of acting as a
direct link between discrete areas of activation and increases in rCBF.
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Since both extrinsic and intrinsic pathways are not likely to provide a
neurotransmitter coupling neuronal activity to rCBF, the only other source
would be release from locally activated neurons. In order for local neurons to
produce an increase in their own blood supply, the transmitter released
should fulfill several requirements. First this substance should be a
ubiquitous substance produced by a wide variety of neurons throughout the
brain. Its release must occur at the onset of increased neuronal activity. It
should be locally diffusable so as to have easy access to the perivascular space
and produce significant vasodilatation. Finally such a transmitter's
production must be tightly controlled and undergo rapid inactivation so that
neurons may fine tune rCBF to transient changes in their activity. Recently
one substance has been shown to produce a wide variety of effects within the
body, including the coupling of rCBF to neuronal activity. This molecule is
Nitric Oxide (NO).

D.) Nitric Oxide: the Mediator Regulating rCBF
NO possesses an extremely simple molecular formula, however over
the last few years a number of very important and increasingly complex
physiological functions have been hypothesized for it (Snyder and Bredt
1992). NO is thought to be the agent responsible for the cytotoxic effects of
macrophages (Guoyao and Brosnan 1992; Stuehr and Nathan 1989), a factor in
the production of long term potentiation (Haley et al 1992), responsible for the
neurotoxicity induced by excitatory amino acids (Dawson et al 1991), and
implicated as the first in a novel class of neurotransmitters (Bredt and Snyder
1992; Dawson et al 1992).
NO is produced by the enzyme nitric oxide synthase (NOS). Several
different isoforms of this enzyme exist; an inducible cystolic enzyme within
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macrophages, a membrane-bound constitutive isoform within endothelial
cells, and a constitutive cystolic enzyme within neurons. The constitutive
isoforms requires a Ca+2/calmodulin co-factor and continually produce NO
(Fostermann et al 1991). Despite different locations these enzymes produce
NO through the same basic reaction. The terminal guanidino nitrogen atom
from the endogenous amino acid L-arginine is oxidized, producing NO and
the amino acid citrulline in a one to one molar ratio (Leone et al 1991;White
and Marietta 1992; Bush et al 1992). NOS has been localized throughout the
central nervous system , with high concentrations in the cerebellum and
dentate gyrus of the hippocampus (Bredt et al 1990). Terminals of NOS
containing neurons have recently been shown to exist in close apposition to
intra-parenchymal vessels within the hippocampus (Nwai 1993).
NO is produced during neuronal activation by an influx of
extracellular Ca+2 through an ionotropic glutamate receptor, the N-methyl-Daspartate (NMDA) receptor (Kiedrowski et al 1992). Although activation of
NOS is primarily thought to occur through this receptor, other glutamate
receptors have also been shown to increase NO production (Okada 1992). The
Ca+2 which enters the neuron binds to the co-factor calmodulin and activates
NOS. NO's release with neuronal activation has lead to the hypothesis that
NO is the first in a novel class of neuro-transmitters . Unlike the classical
neurotransmitters, nitric oxide is produced on demand, is not stored in
vesicles, is released by simple diffusion across the cell membrane, and
interacts with an intracellular receptor, the enzyme guanylyl cyclase (Snyder
and Bredt 1992; Dawson et al 1992). NO activates this enzyme by binding to
the heme moiety and increases the intracellular concentration of cyclic
guanosine monophosphate (cGMP) (Schmidt 1992; Bredt and Snyder 1989).
This increase in cGMP activates the second messenger system and produces

33

various effects, one of which is vascular smooth muscle relaxation and
vasodilatation (Gold et al 1990). NO's ability to act as a vasodilating substance
was proven when it was identified as endothelial derived relaxing factor
(EDRF) (Palmer et al 1987). The exact mechanism of cGMP vasodilatation is
unknown, however two possibilities that have been proposed include a
decrease in intracellular Ca+2, or a hyperpolarization of the smooth muscle
mediated through an ATP sensitive K+ channel (Iadecola 1993). The half-life
of NO is extremely short, in the order of seconds. NO is converted into the
more stable nitroso products including NO2 and NO3 (Snyder and Bredt
1992). There has also been a mechanism proposed in which NO modulates its
own production through a negative feedback loop (Rogers and Ignarro 1992).
Given these characteristics it is clear why NO has become the candidate
of choice to couple rCBF to neuronal activity. NO is a powerful vasodilator, is
released with neuronal activation, is widely distributed throughout the
central nervous system, is locally diffusable, and its production is strictly
regulated. All these abilities point to NO as the missing link between rCBF
and neuronal activity. However, given the complexity of this relationship it
is unlikely that NO is the sole coupling agent. Mediators traditionally
hypothesized, such as adenosine and other neurotransmitters, may still
contribute to this response.

E. Specific Aims
To identify possible mediators coupling rCBF to neuronal activity the
novel combination of intracerebral microdialysis with LDF is applied to the
rat CA-1 /dentate hilus region in the hippocampus. By simultaneously
applying these techniques changes in rCBF can be correlated to the release of
possible regulatory factors in the extracellular fluid. In addition the use of
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microdialysis will enable the local application of pharmacological agents
without inducing other flow regulating tissues.
Neuronal activation is increased by infusing the glutamate receptor
agonist, NMDA. Microdialysis samples will be analyzed for citrulline and
adenosine release. Since NO is degraded so quickly the more stable by¬
product, citrulline, is measured as an index of NO synthesis. The effect of NO
on rCBF will be determined by the direct application of NO within the
interstitium. Inhibitors to NO synthesis will demonstrate that the increase in
rCBF with neuronal activation is in part dependent on NO production. An
antagonist of the P2 purinergic receptor will demonstrate that this response is
not entirely NO dependent but also requires the release of adenosine. Finally
to determine whether the response of rCBF occurs under a normal
physiologic stimulus, the endogenous excitatory pathway to the
hippocampus, the perforant pathway, will be electrically stimulated and
changes in rCBF observed.
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MATERIALS AND METHODS
A. ) Materials
Laser doppler flowmeter and accessories were provided by Perimed,
Inc. (Piscataway, N.J.). Dialysis membrane was made of cuprophan-treated,
regenerated cellulose with a molecular weight cutoff of 5000 daltons
(Glanstoff Inc., Germany). Silica tubing was obtained from Polymicro
Technologies Inc. (Phoenix, Az.). Polyethylene tubing, PE-60, was obtained
from Clay Adams (Parsippany, N.J.). Guide cannulae and brass nuts were
manufactured by Plastic One Inc. (Roanoke, VA.). NMDA and L-arginine
were obtained from Sigma (St. Louis, M.O.). NG-nitro-L-arginine methyl ester
(NAME), S-nitroso-N-acetylpenicillamin (SNAP), and 8-(p-sulfophenyl)
theophylline (8-THEO) were obtained from Research Biochemicals
International (Natick, MA).

B. ) Microdialysis Probe Construction
The microdialysis probe constructed was modified from a previous
design developed by Dr. Matthew J. During (During and Spencer 1991). Silica
tubing was used to construct the inlet and outlet of the microdialysis probe.
Inlet tubing (ID 76 pm) was cut to 60 mm and outlet tubing (ID 97 pm) was cut
to 62.0 mm. A 0.5 inch 23 gauge stainless steel connector was fastened to each
with epoxy. Dialysis membrane was cut to
15.0 mm and sealed at one end with an epoxy plug, less than 1 mm in length.
The outlet of the probe was inserted into the membrane and placed flush
against the epoxy plug. The inlet was inserted and positioned 2.0 mm short of
the epoxy plug, thereby producing a 2.0 mm distance of "active" dialysis

36

membrane. The proximal end of the dialysis membrane was sealed to the
inlet and outlet silica tubing with polyacrylamide. A length of 15.0 mm along
the probe was measured from the tip of the outlet. One end of PE-60 tubing
was splayed by heating while the straight end was inserted through a brass
nut. The tubing was cut so that the distal 15.0 mm of the probe extended
beyond the splayed end. The brass nut was then used to fasten the probe to
the guide cannulae. The probe was inserted through the PE-60 tubing and the
23 gauge metal leads were fastened to the straight end of the tubing with
epoxy. An epoxy plug was then applied to the splayed end at the 15.0 mm
mark, so this distance of the probe remained exposed. This plug prevents the
probe from extending beyond the proper depth once inserted through a
13.0 mm guide cannula. Therefore 2.0 mm of the exposed dialysis membrane
lies within brain parenchyma.

C. ) Guide Cannulae Preparation
Synthetic guide cannulae were cut to 13 mm in length. Stylets were cut
so that 2.0 mm and 1.7 mm would exit the microdialysis and laser doppler
guide cannulae respectively upon insertion. These stylets were inserted at the
time of initial surgery to prepare the neuronal tissue for subsequent
occupation by the microdialysis and laser doppler probes. This significantly
reduces the amount of tissue trauma induced with the subsequent placement
of these probes (Devine et al. 1993).

D. ) Animal Preparation
Male Sprague-Dawley rats (250-350 gms) were anesthetized with a
solution of Ketamine/Xylazine (8/80mg per kg) intraperitoneally (IP).
Animals underwent stereotaxic surgery for unilateral placement of paired
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guide cannulae, through which the microdialysis and laser doppler probes
would be placed into the CAl-dentate hilus of the hippocampus. The
coordinates for the microdialysis guide cannula were 4.3 mm posterior and
2.0 mm lateral from bregma, and the coordinates for the laser doppler guide
cannula were 4.3 mm posterior and 4.5 mm lateral from bregma (Paxinos and
Watson, 1986). The microdialysis guide was inserted at 0.0 degrees from the
vertical and 2.0 mm deep from the outer table of the rats skull. The laser
doppler guide was inserted at +32.0 degrees from the vertical and 2.0 mm
deep from the skull's outer table. Four skull screws were embedded around
the guide cannulae coordinates. The guide cannulae were then placed and
initially held into position with polyacrylamide. Dental adhesive was then
applied around both the skull screws and guide cannulae, the screws
anchoring the dental adhesive to the skull. Stylets were inserted through the
guide cannulae and extended to the approximate depth of both the
microdialysis and laser doppler probes. Animals were allowed to recover for
6 to 9 days. Approximately 24 hours before the experiment a microdialysis
probe was inserted through the guide cannula to a depth predetermined from
the probes construction.

E.) Experimental Protocols
i. Baseline Protocol
Animals were initially anesthetized with a loading dose of achloralose/urethane solution, 0.075 and 0.75 gm/kg IP respectively.
Anesthesia was maintained with intermittent IP injections of achloralose/urethane, approximately 0.015 and 0.15 mg/kg/hr. A heating pad
was used to maintain the axillary temperature of the animal at 38.0 + 1.0
degree Celsius. Animals were placed in the stereotaxic frame to ensure head
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stability, a requirement for movement artifact-free laser doppler
measurements. The entire stereotaxic frame was then placed into a sand bin
on top of three tennis balls which acted as a simplified vibration table. This
eliminated any tissue movement in relation to the laser doppler probe
produced by surrounding vibrations, also ensuring movement artifact-free
measurements. A stainless steel laser doppler light guide, outer diameter of
450 pM, was inserted through its guide cannula and extended to a depth of
1.64 mm beyond the guide, into the dorsal CAl-dentate hilus of the
hippocampus. This would place the laser doppler probe within 1.0 mm of the
microdialysis probe membrane. Figure la. is a schematic representation of
the probe placement, and figure lb. is a sectioned brain showing the paths
produced by both probes and demonstrating their close proximity within the
CA1 /dentate gyrus. Such close proximity is necessary in order for the laser
doppler, with a measuring volume of approximately 2.0 mm^, to monitor the
area influenced by the microdialysis probe. An artificial extracellular fluid
(ECF), made up of 135 mM NaCl, 3.0 mM KC1, 1.0 mM MgS04,1.2 mM
Ca2CF2H20, and 2.0 mM Na2HP04/NaH2P04 to pH 7.4, was infused through
the microdialysis probe at a rate of 2.5 ml per minute. All pharmacological
agents infused were mixed in this artificial ECF and given over 30 minute
intervals. Microdialysis samples were collected for these 30 minute time
periods into microcentrifuge tubes and stored on ice. A baseline of 1.5 hours
was obtained for both laser doppler and microdialysis prior to protocol
initiation. Changes in rCBF were represented as percents of baseline,
accounting for both the increased amplitude as well as the duration of
responses. Microdialysis samples were analyzed for both adenosine and
citrulline with HPLC. Once a baseline was established animals underwent
one of several experimental protocols.
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ii. Response of rCBF to NMDA
Each animal received sequentially increasing concentrations of NMDA
at 50, 100, 200, and 500 jiM, for 30 minute intervals, to determine if rCBF
would respond to neuronal stimulation in a dose dependent manner (n=10).
Between each stimulation period there was a washout of 60 minutes with
artificial ECF to establish a new baseline. Microdialysis samples were
analyzed for both citrulline, an indirect index of NO production, and
adenosine production.
Within this experimental group four animals underwent the protocol
with both arterial and venous catheters placed in femoral vessels. The
arterial line was used to measure systemic blood pressure prior to and during
the time of NMDA stimulation (n=4). Arterial blood was drawn at the
commencement of the study, just prior to, and 15 minutes into the 500 |iM
NMDA dose to measure p02, pC02, pH, and hematocrit (n=3). This group
served as a control to insure that the systemic parameters did not change
during local pharmacological manipulation.
A second group of animals received sequential doses of 200 mM
NMDA (n=4) to determine whether repeated doses of NMDA produced either
a facilitating or desensitizing effect in the response of rCBF to NMDA.

iii. Response of rCBF to NO
After a baseline was established animals were infused with the direct
NO donor S-nitroso-N-acetylpenicillamine (SNAP) at a concentration of 1
mM (n=6). Microdialysis samples were not analyzed.

iv. Response of rCBF to NOS Inhibition
Using the competitive NOS inhibitor, NG-nitro-L-arginine methyl ester
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(NAME), the response of basal and NMDA induced rCBF were observed
during decreased production of NO. After the initial baseline a 200 pM dose
of NMDA was administered. A baseline was re-established with artificial ECF
over a 60 minute time interval. NAME was then infused, at 5 mM, alone to
observe the effects of NOS inhibition on basal blood flow. After this period
both 5mM NAME and 200 pM NMDA were given together to observe if NOS
inhibition would attenuate the response of rCBF to NMDA stimulation.
Microdialysis samples were analyzed for citrulline release (n=8).
Reversal of this inhibition was attempted by simultaneously infusing
the endogenous substrate L-arginine with NAME. The effects of excessive
endogenous substrate alone were also observed. Animals were initially
infused with 100 mM L-arginine, and then immediately with a combination
of both 100 mM L-arginine and 5 mM NAME (n=6). Microdialysis samples
could not be analyzed since the excessive amounts of L-arginine consumed
the derivatizing agents used during HPLC analysis.

v. Response of rCBF to P2 Receptor Blockade
The effects on both basal and NMDA stimulated flow were observed
during blockade of the purinergic receptors with the use of a methyl-xanthine
derivative, 8-(p-sulfophenyl) theophylline (8-THEO) (Ngai and Winn 1993).
After a stable baseline, 200 pM NMDA was infused through the microdialysis
probe. A baseline was re-established with artificial ECF for 60 minutes. Then
500 pM 8-THEO was administered alone, followed immediately with a
combination of 200 pM NMDA and 500 pM 8-THEO (n=5). Microdialysis
samples were not analyzed for the release of adenosine, since the release of
adenosine with NMDA stimulation was demonstrated in the initial protocol.
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vi. Response of rCBF to Perforant Pathway Stimulation
To determine whether an increase in hippocampus rCBF would occur
with synaptic excitation, the perforant pathway was electrically stimulated
with a bipolar electrode. Animals were prepared as in all other groups except
a bipolar electrode was inserted into the perforant pathway on the same side
as the microdialysis and LDF probes. The electrode was inserted at the
following coordinates, 8.4 mm posterior and 4.0 mm lateral to Bregma, to a
depth of 4.8 mm at 0.0 degrees from the skull surface. After a baseline was
established the animal received two stimulation paradigms. The first was a 2
volt stimulus, at frequency of 2Hz , for a 0.1 msec duration, and a total
stimulus time of 20 seconds. After an equilibration period, the same
paradigm was used except the voltage was increased to 5.0 volts.
Microdialysis samples were collected over 5.0 minute intervals before, during,
and after the stimuli.

F.) HPLC Methods
1.) Citrulline Method
Citrulline was analyzed using gradient HPLC with fluorescence
detection and pre-column derivatization with o-phthaldialdehyde (OPA).
The derivatizing stock solution was made monthly and kept at -20 degrees
Celsius. The stock reagent consisted of 10 mg OPA, 25 ml betamercaptoethanol (BME), 0.5 ml of 50mM (pH=9.5) borate buffer, and 4.5 ml
methanol. The working derivatizing reagent was freshly made daily and was
a mixture of 100 ml of methanol, 100 ml of 50 inM (pH=9.5) sodium borate
buffer, and 36 ml of OPA/BME stock solution, which was thoroughly
vortexed. The HPLC consisted of dual Gilson (Westwood, New Jersey) 306
HPLC dual pumps, a 811C Dynamic mixer and 805 Manometric Module, and a

42

Shimadzu (Kyoto, Japan) RF-551 fluorometric detector (excitation of 330 nm
and emission of 440 nm). Mobile phase A was a 0.03 M sodium acetate, 1.0%
tetrahydrofuran solution (pH=6.88) and mobile phase B was a 0.1M sodium
acetate, 80.0% acetonitrile solution (pH=6.82). Sample volumes of 5.0 ml were
mixed with 3.0 ml of reagent with a reaction time of 60 seconds. A total
volume of 7.5 ml was then injected onto a 2.0 X 150 3.0 mm ODS Hypersil
HPLC column (Keystone Scientific, Bellefonte, PA). At the onset of sampling
the percentages of the two mobile phases was 89.5% A and 10.5% B for the
first 14.0 minutes. The percent of mobile phase B was then increased at a rate
of 2.0 % per minute for the next 4.0 minutes with final concentrations of 81.5
% mobile phase A and 18.5% mobile phase B. The total run time was 22.0
minutes. The column was then flushed with 0.5% A and 95.0% B for a total
of 1.5 minutes, with an 8 minute equilibration time.

ii. Adenosine Method
An HPLC system with ultraviolet detection was used for quantification
of adenosine. A BAS200A (BAS, Inc., West Lafayette, IN) system was used
isocratically with the mobile phase consisting of 10 mM NaH2P04 (pH=4.5)
with 5% CH3CN (vol/vol.) pumped at 0.8 ml/min. The column used to
achieve separation was a 3.2 xlO-cm, 3mm Phase-II ODS column (BAS, Inc).
The ultraviolet detector was set at 0.0005 AUFS (absorbance units full scale).
Adenosine eluted within 8 minutes and peak heights recorded on a strip
chart recorder were compared with external standards for quantification.

G.) Statistical Methods
The raw data was log transformed and the overall significance of
treatment groups was determined using repeated measures ANOVA. Post
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hoc differences between individual treatment groups were determined using
Student Paired T Tests. Data is represented as mean + standard error of the
mean, (SEM).

Investigation designs, material constructions, experimental protocols,
data interpretations and statistical analyses were all performed by Michael G.
Kaiser.
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RESULTS
A. ) Baseline
Upon insertion of the laser doppler probe into the rat hippocampus, a
30 minute time interval was allowed before baseline measurements were
attempted. The recordings of the laser doppler were observed to be stable
over an initial baseline period of 90 minutes. The LDF results are displayed as
percent of baseline since blood flow is reported in arbitrary units which
cannot be converted into quantitative values (Dirnagl et al. 1989). Onset of
microdialysis flow did not produce any change in the laser doppler readings.
Data from microdialysis samples are normalized to a baseline of 100% and
represented as a percent change from this baseline.

B. ) Response of rCBF to NMDA
The responses of rCBF to increasing concentrations of NMDA are
summarized in figure 2. As evident from figure 2 there is a dose dependence
of rCBF to NMDA stimulation. The increases were 106.8 +2.3%, 120.0 ±6.3%,
148.0 ± 16.6%, and 191.1 ±20.4% of baseline at 50 |iM, 100 pM, 200 pM, and 500
pM NMDA respectively. An example of the actual recordings from the laser
doppler is shown in figure 3. The data are displayed in trace pairs; the top
trace of each pair is equal to the blood flow, and the lower trace represents the
concentration of moving blood cells. Flow is determined from two variables,
the velocity and the concentration of moving red blood cells. For a more
detailed description see appendix IA. Each response proved to be statistically
significant when compared to baseline values as well as when compared to
the preceding response (p<0.05).
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In the group receiving two sequential doses of 200 pM NMDA, no
statistically significant difference between the responses occurred (p=0.57).
The first response produced an increase of 21.7+4.7%, and the second response
produced an increase of 24.9+6.7%.
Table I. reports the physiological data obtained from the group of
animals which received sequentially increasing doses of NMDA while
systemic parameters were monitored. Although there is a tendency for both
blood pressure and arterial oxygen to fall during the course of the experiment
(7 hours), the infusion of NMDA did not produce any change in any of the
physiologic parameters. There was also no change in blood pressure during
the infusions of 50 pM, 100 pM, and 200 pM NMDA, data not shown.
The responses of citrulline and adenosine are shown in Figure 4a & 4b
respectively. The increases in citrulline at 50 pM, 100 pM, 200 pM, and 500
pM NMDA were 128.9±7.4%, 141.2±15.4%, 147.2±20.4%, and 196.8±22.3% of
baseline. The increases in adenosine at 50 pM, 100 pM, 200 pM, and 500 pM
NMDA were 355.9±112.7%, 1233.5±509.2%, 833.9±378.5%, and 1270.2±958.3%
of baseline. During stimulation periods these increases proved to be
statistically significant from baseline (p<0.05). Although there is a tendency
towards larger increases of citrulline and adenosine with increasing doses of
NMDA, a dose dependent response did not prove to be significant (p>0.10).

C.) Response of rCBF to NO
Direct administration of NO was achieved with the infusion of SNAP.
Figure 5 shows the effects of 1 mM SNAP on rCBF, which increased to
137.0+5.8% of baseline (n=6). This increase proved to be a statistically
significant increase from baseline values (p<0.05).

46

D.) Response of rCBF to NOS Inhibition
The effects of the NOS inhibitor, NAME, were determined for both
basal and NMDA stimulated rCBF. Figure 6 shows the decrease produced
with the infusion of 5 mM NAME during both parameters. When 5 mM
NAME was given alone there was a decrease in rCBF to 77.0±3.0% of baseline
(n=9). After a re-equilibration period 200 |iM NMDA was given alone and
produced an increase to 160.4+9.2% of basal flow. This response was
decreased but not abolished with co-administration of 5 mM NAME to
125.0±6.6% of baseline, which represents a 56.6±10.0% decrease in the
response (n=6). The decreases produced by 5 mM NAME from both basal and
NMDA induced flow were statistically significant (p<0.05). Microdialysis
samples were analyzed to determine if extracellular concentrations of
citrulline would decrease with NOS inhibition, see figure 7. During
administration of 5 mM NAME alone there was a decrease in extracellular
levels of citrulline to 64.1+5.9% of baseline values. Citrulline levels increased
to 134.1+4.4% of baseline during 200 pM NMDA administration. This
increase was blocked when 5 mM NAME was given in combination with
NMDA, to a value almost identical to when NAME was given alone,
67.6+9.2% baseline. Statistically significant differences occurred between the
decreases in citrulline with 5 mM NAME when compared to both baseline
and NMDA induced levels of extracellular citrulline (p<0.05).There was no
significance between the two values of citrulline during NAME infusion
(p>0.10)
The results obtained with infusion of excessive endogenous substrate
alone and with 5 mM NAME are represented in Figure 8. When 100 mM Larginine is given alone there was an increase of rCBF to 113.3±2.9% of
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baseline flow. As shown previously the decrease in rCBF produced by 5 mM
NAME was 77.0+3.0% of basal flow. This decrease is antagonized when
100 mM L-arginine is given in combination with 5 mM NAME to 92.6+2.2%
of basal flow. The increase from basal flow and the attenuation of the 5 mM
NAME response produced with 100 mM L-arginine were statistically
significant (p<0.05). Microdialysis samples were unable to be analyzed for this
group.

E. ) Response of rCBF to P2 Receptor Blockade
The results obtained with blockade of the adenosine receptors are
shown in Figure 6, along with the results of NOS inhibition. Antagonism of
the adenosine receptor was carried out under baseline conditions as well as
with NMDA stimulated flow. When 500 pM 8-THEO was given alone, rCBF
was decreased to 74.9+2.0% of baseline (n=7). This decrease was statistically
significant (p<0.05). In this experimental group the increase produced by 200
pM NMDA was 138.0+8.0% of baseline. Attenuation, but not obliteration, of
this response occurred when 500 pM 8-THEO was given in combination with
200 pM NMDA. The increase in rCBF was only 108.0+3.4% of baseline,
representing a 78.7+7.8% decrease in the response produced with NMDA
stimulation alone (n=5). This decrease was statistically significant (p<0.05).

F. ) Response of rCBF to Perforant Pathway Stimulation
The effects on rCBF of a synaptic stimulation in the CA1/dentate hilus
of the rat hippocampus were examined by electrically stimulating the
perforant pathway with a bipolar electrode. The results are demonstrated in
Figure 9. There was a clear difference between the two stimulus paradigms,
with the 5 volt stimuli producing a peak increase in flow of 179+5.4% of
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baseline and the 2 volt stimulus producing an increase of 122.0+2.8% of
baseline (n=2). The difference between these response and between the
responses and baseline proved to be statistically significant (p<0.05). The
onset of both responses occurred at the same time with stimulation onset,
however the duration of the 5 volt response is maintained above baseline for
25 seconds after the stimulus, while the response to 2 volts returns to baseline
values within 10 seconds.
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DISCUSSION
A.) The Combination of LDF and Microdialysis
The primary goal of this study was to determine whether or not both
NO and adenosine participate in the coupling of rCBF to local increases in
neuronal activity. In order to carry out this investigation however, an
improvement on previously used methods was necessary. Therefore a
secondary goal was to demonstrate that the novel combination of two existing
techniques, LDF and microdialysis, would be an effective methodology. The
primary advantage of using both techniques simultaneously is the ability to
characterize potential mediators released into the extracellular environment
while continuously measuring rCBF for sudden changes. In addition,
microdialysis enables a localized administration of pharmacological agents,
producing increased neuronal activity, without affecting the release
vasoactive substances from other tissues.
The first in vivo laser doppler measurements of blood flow were done
in 1972 by Riva and colleagues studying the flow of rabbit retinal vessels (Riva
et al 1972). Since that time the use of laser doppler has expanded to measure
the microcirculation in a variety of tissues from the skin to the central
nervous system. The validity of laser doppler has been established through
the many studies comparing it with other pre-existing techniques which
monitor local tissue blood flow. These include plethysmography (Johnson et
al 1984), xenon clearance (Olsson 1986), and transcutaneous oximetry (Allen
and Goldman 1987). In the central nervous system laser doppler has been
compared to radionuclide labeled microspheres (Eyre et al 1988), [C^]
iodoantipyrine measurements (Dirnagl et al 1989), and hydrogen clearance
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(Haberl et al. 1989), and found to have correlation coefficients of 0.92, 0.91, and
0.97, respectively. These studies concluded that the laser doppler was best
suited for continuous measurements of cerebral blood flow in which rapid
changes were to be observed. It is this ability of the laser doppler, to make
real-time measurements of blood flow, which gives it an advantage over pre¬
existing techniques to investigate the coupling of rCBF to neuronal activity.
Microdialysis has become the most stabilized technique to sample the
neuronal extracellular fluid for the release of various transmitters. The
method has progressed to the point of utilization in the conscious human
brain (During and Spencer 1992; During and Spencer 1993). The sampling of
adenosine has been done in a variety of studies, and the method is well
established (Zetterstrom et al., 1982; Hagberg et al, 1987; During and Spencer
1992). Direct measurements of NO using microdialysis are currently
impossible given its extremely short half-life, in the order of seconds (Snyder
and Bredt 1992) and its extremely low basal concentrations, reported to be
10"8 M (Malinski et al. 1993). For these reasons we chose to measure the
release of citrulline, an amino acid which is produced in a 1:1 molar ratio
with nitric oxide (Leone et al. 1991; Bush et al. 1992). Amino acids are
commonly measured in microdialysis samples, and a change in citrulline
production has been used as index of NO synthesis in the past (Rogers and
Ignarro 1992; Snyder and Bredt 1992).
In addition to the more common use of microdialysis, to measure the
concentration of substances in the interstitium, it also enables the local
delivery of pharmacological agents to the extracellular environment. This is
particularly important for this investigation because intravenous application
of substances could produce systemic effects or influence vascular endothelial
cells to change blood flow in the hippocampus. Such a response could not be
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attributed solely to neuronal activity. For this study the glutamate agonist
NMDA, was infused to produce a local increase in neuronal activity. Since
NMDA has been shown to have no direct effect on vascular smooth muscle
(Faraci and Breese 1993) and as astrocytes do not express functional NMDA
receptors (Bowman and Kimelberg 1984), the changes observed in blood flow
can be assumed to be produced from the local activation of neurons. In
addition the results displayed in Table I demonstrate that no significant
changes in the systemic parameters occurred with the application of NMDA
through the microdialysis probe.
The major problems with the combined technique are the intracerebral
surgical placement of the laser doppler probe in relation to the microdialysis
probe, the trauma induced by probe insertion, and the need for an
anesthetized animal to avoid movement artifact. Because of the limited
volume of tissue measured by the laser doppler, the tip of the probe has to be
within 1.0 mm of the dialysis membrane. This insures that the doppler
monitors the neuronal environment manipulated by substances infused
through the microdialysis probe (see Figure la & lb). The larger the volume
of activated tissue measured by the laser doppler, the more likely a response
will be observed. This variability in surgical placement undoubtedly
produces a considerable variation between animals, and cannot be avoided
without direct observation of the tissue at the time of implantation.
The majority of cerebral laser doppler studies have been limited to
measurements of surface cortical flow. The stereotaxic implantation of the
laser doppler enables the measurements of deep structures, however this may
lead to significant tissue trauma. In this study such trauma is limited
through the use of metal stylets which are inserted during the initial surgery.
The stylets, placed through both microdialysis and laser doppler guide
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cannulae, limit the acute injury in the tissue occupied by the probes at the
time of their subsequent insertion through the guide cannulae. This pre¬
placement of stylets has recently been shown to enable measurements of both
calcium and TTX dependency of neurotransmitter release within two to three
hours of microdialysis probe placement (Devine et al 1993).
In order to obtain accurate results with the laser doppler, the tissue
examined must remain motionless in relation to the laser doppler probe,
requiring an anesthetized animal. Unfortunately many anesthetics have a
significant effect on the cardiovascular system, cerebral blood flow, and
neuronal activity. For this study we chose to use a combination of achloralose and urethane. This anesthetic regimen has major advantages over
other anesthetics. a-Chloralose/urethane has been shown to produce stable
laser doppler recordings of cerebral blood flow and not inhibit blood flow
response to stimulation (Lindauer et al 1993), it preserves the coupling of
cerebral function to cerebral metabolism (Ueki et al 1992), and it has limited
effects on the cardiovascular system (Alvarez-Buylla 1951; Bijagkuman 1956).
Due to these characteristics the combination of a-chloralose/urethane is
particularly suited for this type of study.
In spite of the limitations - the degree of accuracy needed with surgical
placement, the tissue trauma produced, and the need for an anesthetized
animal - it is evident from the results obtained in this study that this
combination of techniques has definitely proven to be a powerful tool in the
investigation the coupling between rCBF and neuronal activity.
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B.) NO and Adenosine:
Mediators Coupling rCBF to Neuronal Activity
Based on previous studies investigating the relationship between rCBF
and neuronal activity, we expected to observe an increase in blood flow with
the activation of hippocampal neurons. Neuronal activation was produced
through the infusion of NMDA through the microdialysis probe. NMDA is a
specific glutamate receptor agonist which acts at the receptor named after
itself, the NMDA receptor. These receptors have been identified throughout
the hippocampus with the highest densities in the CA1 and dentate hilus,
targets of the Schooner collateral and perforant pathway respectively (Cotman
and Iversen 1987; Cotman et al 1988). With exogenous application of NMDA
or endogenous release of excitatory neurotransmitters, such as glutamate and
aspartate, the receptor complex is stimulated and activates a voltage sensitive
ion channel. As with other glutamate receptor channels an efflux of Na+ and
an influx of K+ occurs with activation, but in addition the NMDA gated
channel allows an influx of Ca+2 ions (Ascher and Nowak 1987).
Since the activation of neuronal NOS is dependent on Ca+2, the ability
of the NMDA receptor to increase intracellular Ca+2 has linked it to the
activation of NOS and NO production (Snyder and Bredt 1992). This has
previously been shown to occur in suspensions of cerebellar cells in vitro
(Garthwaite et al 1988). In order for NO to participate in the regulation of
rCBF in the hippocampus there must be neurons within this region shown to
contain NOS. Using immunohistochemical treatments this enzyme has been
localized throughout the brain, including the hippocampus, particularly the
dentate hilus (Bredt et al 1990). Another technique to localize NOS
containing neurons is to stain for NADPH diaphorase. In the oxidation of Larginine to NO, a co-factor is required to donate electrons. This function is
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carried out by NADPH. It has been shown that staining for NADPH
diaphorase is actually a means of staining for NOS since this enzyme is the
sole source of NADPH activity in neurons (Snyder and Bredt 1992). Using
this technique it has more recently been shown that NOS containing neurons
within the hippocampus have processes intimately related with microvessels
(Schottler et al 1993). Therefore the elements necessary to produce NO are
present in the hippocampus.
Adenosine release has also been shown to occur within the
hippocampus. During electrical stimulation of rat transverse hippocampal
slices an increase in the release of adenosine occurs. This release is in part
Ca+2 dependent and has been thought to occur by both classic
neurotransmitter mechanisms and via breakdown of cellular AMP during
increased metabolism (Jonzon and Fredholm 1985). NMDA has been shown
to be a powerful stimulator of adenosine release. At a concentration of 30 |iM
NMDA a maximal response of adenosine release was produced in rat brain
slices (White et al 1993). In order to produce a vasodilating effect adenosine
must interact with a specific class of purinergic receptor, the P2 receptor (Ngai
and Winn 1993). The existence of such receptors within the hippocampus has
been demonstrated through increases in cAMP production with adenosine
application in vitro (Fredholm et al 1982). As with NO all the necessary
elements for adenosine to mediate the coupling of rCBF to neuronal activity
are present in the hippocampus. In addition adenosine has also been
hypothesized to have other important neuromodulatory effects in the
hippocampus, such as acting as the mediator of seizure arrest (During and
Spencer 1992).
If a direct relationship exists between neuronal activity and rCBF, one
would expect larger increases in activation to produce greater increases in
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rCBF. We observed such an effect by increasing the concentrations of NMDA.
From the results it is clear that a dose dependent response of rCBF to
neuronal stimulation occurs in the hippocampus. However this could also
be explained by a potentiation of mediator release due to subsequent
stimulations, instead of increasing activity levels. Such a mechanism has
been described to explain long term potentiation within the hippocampus.
Our data do not support this notion since repeated stimulation with the same
concentration of NMDA did not produce any facilitation in the response of
rCBF. It can therefore be assumed that the response of rCBF is activity
dependent, and by increasing the concentration of NMDA an increase in
activity is achieved by either increasing the number of activated neurons
and/or increasing their firing frequency, leading to a heightened response in
rCBF.
Both adenosine and citrulline, an indirect index of NO production,
increased as expected with NMDA stimulation. Each displayed an increase in
their extracellular concentrations, although a dose dependence did not prove
to be significant. The increase in citrulline does not definitively indicate an
increase in NO. Other sources of citrulline exist, such as the urea cycle.
Therefore the effect of NOS inhibitors must be assessed in order to determine
if the citrulline measured by microdialysis is at least in part produced through
the formation of NO. Although a dose dependent response in citrulline
release did not prove to be significant, a general trend toward increasing
release with increasing concentrations of NMDA is apparent. The increase of
adenosine is more complex than that of citrulline since there was a
considerable, but not statistically significant, decrease in the concentration at
200 pM NMDA. This could possibly be explained by a recent study which
demonstrated an inhibitory effect of NMDA neurotransmission through
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extracellular adenosine release. This inhibition is thought to occur at a
presynaptic PI purinergic receptor, and can be overcome by excessive
amounts of NMDA, at concentrations of 500 pM NMDA. This excess of
glutamate agonist is hypothesized to activate a spare group of NMDA
receptors (White et al 1993). Perhaps this is a mechanism by which adenosine
is able to modulate its own release as well as the release of other
neurotransmitter.
Although the concomitant increase in the proposed mediators and
rCBF lends support to the hypothesis that they mediate the increase in rCBF it
does not establish a cause and effect relationship. To strengthen this
hypothesis one can demonstrate increases in rCBF with direct application of
the possible mediator, or show that the response of rCBF during activation is
decreased by inhibiting the production or action for these mediators. Direct
application of NO through the infusion of SNAP produced a significant
increase in rCBF. These results are not surprising and only support the
vasodilator action of NO.
NAME acts as a competitive inhibitor of NOS, and therefore will
decrease the production of NO. If NO is a mediator which couples rCBF to
neuronal activity then by inhibiting its production the response of rCBF
during activation should be decreased. The response of rCBF to NMDA was
significantly decreased but not abolished with the infusion of NAME,
indicating that the response of rCBF during neuronal activation is only in
part mediated by NO. In addition there was a significant decrease in the
amount of citrulline produced with NMDA stimulation during NAME
infusion. This supports the hypothesis that citrulline can act as an index of
NO production, and that the increase of citrulline occurring with NMDA is
accompanied by an increase in NO. The amount of NAME used may be
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sufficient to produce a total block of NO production since there was no
difference between the concentrations of citrulline when NAME was given
alone and with NMDA. Since NAME is a competitive inhibitor its effects
should be attenuated with the application of the endogenous substrate,
L-arginine. When combined with L-arginine, the decrease produced by
NAME in rCBF was not as great as when NAME was given alone. In addition
it appears that additional administration of endogenous substrate increases
rCBF. Both of these responses are presumably due to an increase in the
production of NO. These claims however could not be substantiated since the
inclusion of such a high concentration of L-arginine in microdialysis samples
precluded analysis. The excessive amounts of L-arginine utilized all the
derivatizing agent, necessary to identify amino acids with HPLC analysis.
Even so, these results support the hypothesis that NO plays a part in coupling
rCBF to neuronal activation.
The effects of inhibiting adenosine vasodilatation also show that the
response of rCBF to NMDA stimulation is in part mediated through the
release of adenosine. The antagonism of the response is produced by blocking
the receptor for adenosine instead of blocking its production. The agent used
was a derivative of the methyl-xanthine drug group, which includes caffeine,
8-THEO. This agent is not specific for either the Pi or P2 purinergic receptor,
however its ability to antagonize adenosine vasodilatation is mediated
through blockade of the P2 receptor (Ngai and Winn 1993). As with NAME,
the response to NMDA stimulation was also attenuated with 8-THEO,
indicating that adenosine is necessary to couple rCBF to neuronal activation.
Although blocking the action of both mediators attenuated the
response of rCBF to NMDA activation, 8-THEO produced a greater percentage
decrease in the response than NAME. A possible explanation for the
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seemingly more powerful effect of adenosine in rCBF may be due to the fact
that adenosine is released as both a neurotransmitter and metabolite.
Therefore two sources allow a greater accumulation of the mediator and a
greater response produced. A more likely explanation comes from recent data
which demonstrated a 50% reduction of the response of rCBF to adenosine
with the administration of a NOS inhibitor (Niwa 1993). A hypothesis which
may explain these results is that adenosine may activate flow through two
mechanisms. A direct mechanism by binding to the P2 receptors and
increasing intracellular cAMP, and an indirect mechanism by activating the
production of NO. Adenosine may activate NO production by binding to
presynaptic receptors which have previously been hypothesized to modulate
neurotransmission in the hippocampus (Dunwiddie 1980). Adenosine may
therefore play a very complex role in the regulation of rCBF. Not only
because of two sources of production, but also by increasing rCBF through
direct vasodilatation, and by increasing NO production.
There may also be a role for both NO and adenosine in maintaining
basal blood flow within the hippocampus. Both mediators are capable of
being synthesized and released outside of the classic neurotransmitter
mechanisms, and are therefore action potential independent. Adenosine can
be released through the metabolic pathways, and the constitutive isoform of
NOS is continually producing NO which simply diffuses out of the cell. It is
possible that these two mediators are released during basal neuronal activity
and maintained at a certain extracellular concentration, enough to exert a
tonic effect. This is evident from the data obtained when both NAME and 8THEO were applied alone. In both cases a significant decrease in baseline
rCBF occurred. In addition the decrease in citrulline produced when NAME
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is given alone indicates that a certain amount of NO is produced by the
neuron even when it is not stimulated.
Although the application of NMDA produces neuronal activation this
is not a physiological form of stimulation within the hippocampus. In order
to determine if this response is indeed occurring during normal physiological
activity an endogenous stimulation must be applied. This was carried out
through the electrical activation of the perforant pathway. This pathway
delivers a major sensory input to the hippocampus from the entorhinal
cortex. This cortical structure in turn receives input from association cortices,
the olfactory cortex, thalamic nuclei, and the amygdala. The perforant
pathway enters the hippocampal fissure and terminates throughout the
hippocampus, however the dentate gyrus contains a high density of fibers.
Here the terminals of the perforant pathway make excitatory synapses on the
spines of granule cells (Brown and Zador 1990). Stimulation of the perforant
path should produce an increase in the local activity of the dentate gyrus and
produce an increase in rCBF to this area. This assumption is confirmed by the
results obtained from this study. Not only was a definite increase in rCBF of
the CA1/dentate hilus produced with stimulation of the perforant pathway,
but this response appears to be dose dependent. This is evident from the
statistically significant differences between the increases occurring with the 2
volt and 5 volt stimuli. Unfortunately at the present time the level of
citrulline and adenosine have not been determined for these microdialysis
samples due to a technical error in equipment and lack of time. This data
however will be available shortly.
Based on these results it seems clear that both NO and adenosine act to
couple rCBF to increasing neuronal activity within the CA1/dentate hilus of
the hippocampus. These mediators are not likely to be unique to the
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hippocampus, and probably mediate this response throughout the central
nervous system. Both are potent vasodilators, are present throughout the
brain, released with increasing neuronal activity, and are themselves tightly
regulated, all the characteristics necessary for a ubiquitous coupling agent.
Since the increases in the two putative mediators did not parallel the change
in blood flow, and inhibiting these mediators could not totally abolish the
response of activated flow, additional factors are likely to be involved. Given
the host of other candidates this is very possible (Iadecola 1993). In addition
since adenosine has been shown to have a negative effect on NMDA receptor
neurotransmission (White et al. 1993), and that NO has a negative feedback
on NOS (Rogers and Ignarro 1992), a simple linear relationship between the
release of these mediators and effects on rCBF is unlikely. At this juncture a
plausible scenario within the hippocampus, and other areas of the brain, is
that NO and adenosine act to initiate the response in rCBF, but the classical
mediators, such as metabolites, help to augment the flow during sustained
activation.
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CONCLUSIONS
From the results obtained the following conclusions can be drawn:
1. The combination of LDF and intracerebral microdialysis is a
valuable tool to investigate the coupling of neuronal activity to rCBF. LDF
allows continuous monitoring of rCBF and microdialysis characterizes the
extracellular fluid for the release of possible mediators. Also microdialysis
can deliver various pharmacological agents to manipulate the local neuronal
environment without involving additional tissues.
2. Neuronal activation is coupled to rCBF in a dose dependent
manner, under both pharmacological stimulation using NMDA, and synaptic
stimulation by electrical stimulation of the perforant pathway. This
heightened response may be due to an increase in the number of neurons
releasing transmitter and/or an increase in the amount of transmitter
released by each neuron.
3. Both NO and adenosine are involved in the coupling of rCBF to
neuronal activity, and are also involved with maintaining basal flow. During
stimulation with NMDA both agents demonstrate an increased concentration
in the extracellular fluid. The response of NMDA induced rCBF was
antagonized by the application of an inhibitor to NO synthesis and a receptor
blocker to adenosine. The antagonism of the NOS inhibitor is reduced when
an excessive amount of the endogenous substrate for NO synthesis is
available. When these substances are given under baseline activity there is
also a significant reduction of basal rCBF.
Figure 10 is a schematic presentation of how NO and adenosine may
mediate an increase in rCBF.
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4. It is likely that additional factors are involved in this relationship
since inhibiting either NO or adenosine could not abolish the response
produced with NMDA stimulation.
5. Measuring the extracellular concentrations of citrulline is an
indirect measure of NO production. The extracellular concentration of
citrulline increased during NMDA stimulation and decreased with
application of NAME, the inhibitor to NO synthesis. This is the pattern
expected of NO release as well.
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TABLE I

Physiological Parameters at the onset of
experiment, prior to 500 |iM NMDA, and
during 500 pM NMDA stimulation.

Blood Pressure (mm
Hg)
PO2 (mm Hg)
PCO2 (mm Hg)
PH
Hematocrit

Basal

Pre SOOfiM

500jiM

119.5 ±13.0

93.7 ±9.9

95.0 ± 10.6

78.1 ±4.1
38.1 ± 1.4
7.39 ± 0.01
39.0 ± 0.6

64.9 ± 5.5
37.0 ± 3.8
7.38 ± 0.04
35.3 ± 2.7

67.1 ±4.5
35.8 ±3.4
7.39 ± 0.03
37.0 ±2.1

Table I. Data is represented as the mean + SEM. Blood pressure measurements are based
on n=4, and blood gas parameters are based on n=3. No statistically significant differences
occurred between any of the parameters.
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FIGURES

Figure la. Schematic representation of a posterior view outlining the microdialysis
and laser doppler probe placement into the CA1/dentate hilus of the rat hippocampus. Each
division of grid equals 200 pm. Both microdialysis and laser doppler probes are drawn to scale.

Figure lb. Photograph
demonstrating the anterior view of a
rat brain slice. Defect produced by the
microdialysis probe is on the right and
by laser doppler probe on the left. Each
division represents 1.0 mm.
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Response of Hippocampal Blood Flow to
NMDA Stimulation

Figure 2. Local hippocampal blood flow responds to increasing concentrations of
NMDA in a dose dependent manner. Data are represented as % of baseline flow ± SEM. The
increase at 50 pM is 106.8±2.3%, at 100 pM is 120.016.3%, at 200 pM is 148.0116.6%, and at
500 pM NMDA is 191.4 ±20.4%. Each increase proved to be a statistically significant from the
baseline and from preceding responses (p<0.05).
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Laser Doppler Recordings

500|iM NMDA

Figure 3. Laser doppler recordings demonstrating the dose dependent response of
rCBF to increasing concentrations of NMDA. The top trace of each pair represents blood flow
and the lower trace is the concentration of moving blood cells. The arrows indicate the
approximate arrival time of NMDA to the tissues and the values used for baseline blood flow.
Each vertical division of chart paper represents 20 seconds.

Response of Extracellular Citrulline to
NMDA Stimulation

0

50

100

200

500

Concentration of NMDA (|iM)
Figure 4a. Extracellular citrulline increases with NMDA stimulation. Data are
represented as % of baseline levels ± SEM. The increase at 50 pM is 128.9±7.4%, at 100 pM is
141.2+15.4%, at 200 |iM is 147.2±20.4%, and at 500 pM NMDA is 196.8±22.3%. All responses
proved to be statistically significant from baseline values, but a dose dependent response did
not prove to be statistically significant (p<0.05).

Response of Extracellular Adenosine to
NMDA Stimulation

Figure 4b. Extracellular adenosine increases with NMDA stimulation. Data are
represented as the % of baseline adenosine ± SEM. The increase at 50 pM is 355.6±112.7%, at
100 pM is 1233.5+509.2%, at 200 pM is 833.9+378.5%, and at 500 pM NMDA is 1270.2+958.3%.
All responses proved to be statistically significant from baseline values, but a dose dependent
response did not prove to be statistically significant (p<0.05).
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Response of Hippocampal Blood Flow to
SNAP
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Figure 5.

Infusion of the NO donor, SNAP, produces an increase of 137.0+5.8% of
baseline. The increase in rCBF was statistically significant from baseline (p<0.05).
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Effect of NAME and 8-THEO on Baseline and
NMDA Induced Hippocampal Blood Flow
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Figure 6.

Both NAME and 8-THEO decrease basal rCBF and attenuate the response
to NMDA stimulation. 5mM NAME reduces rCBF to 77.0±3.0%(n=9) of baseline and 500 pM 8THEO to 74.9+2.0% (n=7) of baseline. The response to 200 pM NMDA is reduced from
164.0+17.4% to 125.G±6.5% of baseline with 5mM NAME (n=7) and from 138.0±8.0% to
108.0+3.4% of baseline with 500 pM 8-THEO (n=5). Each reduction from baseline as well as
from NMDA stimulated flow proved to be statistically significant (p<0.05).
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Effect of NAME on Baseline and NMDA
Stimulated Extracellular Citrulline Release
140
Baseline
NMDA only
120

0)

a

f-H
3

b

a> u
c/3

100
80

u

o

in
3
fH

£3
u

60
40

b

X
0)

20
0
0

0

200

200

Concentration of NMDA (|uM)
Figure 7.

NAME decreases the level of extracellular citrulline from baseline and
reduces the response to NMDA stimulation. Infusion of 5mM NAME decreases basal
extracellular citrulline to 64.1±5.9% of baseline. The response of extracellular citrulline to 200
(iM NMDA is attenuated from 134.1±4.4% to 67.6±9.2% of baseline. The decreases produced by
5mM NAME from basal and NMDA stimulated levels of extracellular citrulline were both
statistically significant (p<0.05). There was no statistically significant difference between the
decreases in extracellular citrulline produced by 5 mM NAME under basal and NMDA
stimulated conditions.

Effect of L-arginine to Baseline and NAME
Reduced Hippocampal Blood Flow(n=6)
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Figure 8.

L-arginine increases basal rCBF and inhibits the decrease produced by
NAME. 100 mM L-arginine alone increases rCBF to 113.0+2.9% of baseline, and attenuates the
response to 5 mM NAME from 77.0+3.0% to 92.6+2.2% of baseline. The increase produced from
baseline and the attenuation of the response to 5 mM NAME both proved to be statistically
significant (p<0.05).
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Response of Hippocampal Blood Flow to
Perforant Pathway Stimulation (n=2)

-10

0

10

20

30

40

50

Time (sec)
Figure 9. The data obtained thus far demonstrate that hippocampal blood flow
responds to perforant pathway stimulation in a dose dependent manner. The response to
5 volts reached a peak at 179.0+5.4% of baseline, while the response to 2 volts only peaked at
122.0+6.0% of baseline. Even with two subjects, a statistically significant difference between
the two responses was demonstrated (p<0.05). In addition the response from 5 volts lasted 25
seconds after the stimulus while with 2 volts baseline flow was obtained only 10 seconds after
stimulus. Each response occurred at the onset of stimulation without an appreciable time lag.
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Schematic representation of the mechanisms by which NO and adenosine may increase rCBF. The
upper portion of the diagram is the NO pathway. The bottom half demonstrates the three ways in
which adenosine is released to increase rCBF; (1) through the extracellular breakdown of neuronally
released AIT, (2) through the direct release as a neurotransmitter, and (3) from the breakdown of AMP
through the metabolic pathways of the cell. Not demonstrated in this diagram is the possible effect in
which adenosine may stimulate NO release.
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APPENDIX
A.) Laser Doppler Flowmetry
i. History

Only four years after the experimental development of the laser
(Maiman I960), flow profiles in transparent tubes were demonstrated by
utilizing laser light (Yeh and Cummins 1964). This lead to its use in
measuring air flow in wind tunnels, and was known as laser doppler
anemometry (Durst et al 1976).
In 1972 the first measurements of blood flow using laser doppler
techniques were done in the rabbit retina (Riva et al 1972). The technology at
this time required the use of a 10 mW laser to overcome the low signal to
noise ratio. Not until improvements in the system occurred, allowing a
reduction in the power of the laser to 18 pW, were blood flow profiles in the
human retina possible (Tanaka and Riva 1974). Laser doppler has also been
coupled to microscopes (Einav et al 1975) and optical fibers inserted directly
into blood vessels (Kajiya et al 1981) in order to obtain blood flow profiles. In
1975, Stern used a 15 mW He-Ne laser to measure blood flow through the
skin micro-circulation during alcohol intake and increased venous pressure.
Laser doppler was introduced for clinical use by Holloway and Watkins in
1977, however one year later these same authors demonstrated that
measurements could only be made only 50% of the time due to mode
competition in the laser cavity (Watkins and Holloway 1978). These
difficulties were overcome with the development of a dual channel detector
system, which increased the signal to noise ratio, and a signal processor which

'

gave a linear response to flow under low to moderate red cell velocities and
volumes (Tenland 1982).

ii. Interaction of Laser Light within Tissues
Laser light which illuminates a tissue will be scattered in a diffuse
pattern due to the variations in the tissue refractive index. The depth of
penetration is dependent on a number of variables, including the wavelength
of laser light used (in this study the wavelength was 632.8 |im - red light), the
pigmentation of the tissue, and the hemoglobin content of the tissue. Light is
predominantly scattered by static tissues, however a component of the
incident light will be scattered by mobile tissues, i.e. blood cells. This light
will undergo a frequency shift according to the Doppler effects. Light which is
reflected directly back to its source will undergo the maximum frequency
shift. In tissues with a high density of moving blood cells the light will
undergo a multitude of frequency shifts. Most of the light incident on the red
blood cells is reflected forward, away from its origin, secondary to the
irregular shape of the cells, their high refractive index, and since their size is
greater than the wavelength of laser light, according to the Rayleigh-Debye
theory. Therefore the magnitude of frequency shifted light returning to the
source is smaller than light which is scattered from static tissue.

iii. Detection of the Reflected Laser Light
Light which returns to the doppler unit is presented to the
photodetectors. If the light were scattered by a stationary object, the beam
would produce a speckle pattern from the positive and negative interferences
of the light. If a portion of this light is reflected from a moving object the
intensity of the speckle pattern will be less pronounced. This is due to rapid

fluctuations in the interference pattern caused by the shifting in frequencies
according to the Doppler effect. The naked eye would be unable to detect
these changes in speckle pattern, however a rapid photodetector could. These
fluctuations are based on the magnitude and frequency of the number of
objects in motion and their velocities. The photodetector monitors the
individual changes of each granule making up the speckle pattern and by
adding them together produces an output signal. The magnitude of this
signal is proportional to the square root of the number of fluctuating speckle
points detected.

iv. Derivation of Photodetector Output Signal
Returning laser light is composed of both shifted and unshifted light,
which produces three forms of output. A DC-term which is proportional to
the intensity of returning light, a homodyne term which is composed of the
Doppler shifted light, and a heterodyne term which is composed of both
Doppler shifted and unshifted light. In tissues with low to moderate red cell
densities the homodyne term will drop out since the average of shifted light
is insignificant compared to the average of unshifted light. An output signal
is then generated based on the following equation:

Vout={k0J00coP(o)) dco}
Vout

= output signal; ko = constant; P(co) = power spectral density

In tissues with a high density of red blood cells, e.g. a dilated fingertip, this
relationship is not valid since the homodyne term is no longer insignificant
and an incident beam of light undergoes multiply scattering.
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Ideally the laser doppler should utilize a monochromatic source of
light, however small amounts of variation in both frequency and amplitude
of the light illuminating the tissue will occur. These variations will produce
mode interference on the photodetector which will induce error in the laser
doppler recording. This limitation is overcome with the use of a pair of
photodetectors, and forming the difference between the two output signals.

v. Converting the Photodetector Signal into Useful Information
The signal produced by the photodetector must be processed in order to
gain useful information. This is done by the conversion into a continuous
real-time electrical signal which can be transmitted to a computer or chart
recorder and is a reflection of the blood flow. In order for this to be accurate
two assumptions are necessary:
1. The portion of laser light undergoing a frequency shift is
approximately linearly related to the volume of moving blood cells.
2. The average frequency shift is proportional to the average red
blood cell velocity.
These assumptions have been proven to be correct in tissues of low to
moderate red blood cell density. A signal processor is therefore able to obtain
an output which is linearly related to the flow of red blood cells, which is
equal to the number of moving red blood cells multiplied by their velocity.
In highly perfused tissues these assumptions are less than ideal secondary to
an increased complexity between the frequency shifts and flow of red blood
cells and a decreased penetration of the laser light.

vi. The Laser Doppler Unit
The main unit contains a He-Ne laser which emits a beam with a
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wavelength of 632.8 pm, in the spectrum of red light. This laser light is sent
to the tissue through a fiber optic guide. The light guide for this study
contained three parallel optical fibers arranged in a triangular configuration.
One acts as the emitting fiber from which the laser light enters the tissue. The
remaining two optical fibers act as receivers and return the scattered light to
the doppler unit. Variations in the distance between the two receiving fibers
will increase the depth of measurements since light reflected by a greater
angle can be received.
The returning light enters the doppler unit and is processed by the pair
of photodetectors. The output signal of each detector is sent to the signal
processor which transforms the outputs into an electrical signal which drives
a pen on a chart recorder. A hard copy of the laser doppler results is obtained
and the percent increase from baseline can be determined.

B.) Microdialysis
i. History
In order to obtain an understanding of the factors which mediate
cellular responses the extracellular fluid compartment has to be analyzed.
Determining the concentrations of substances in the plasma cannot be used as
a reflection of the interstitial concentration since the substance may have
completely different kinetics between the two compartments. Various
methods have been applied to obtain the interstitial concentrations of various
substances, however the one technique which has become the standard,
especially in measuring brain interstitial fluid, is microdialysis.
In the mid 1960's the idea of a separate compartment surrounded by a
dialysis membrane was introduced. These initial studies utilized a "dialysis
sac," containing a solution of 6% dextran in normal saline, which equilibrated

with the extracellular environment. This sac was implanted into the tissues
and after a certain time period removed so that the substances within the sac
could be measured (Bito et al 1966). This idea progressed into the "dialytrode"
which consisted of a push-pull cannula with a dialysis membrane connecting
the inlet and outlet (Delgado et al 1972). A simple version of the
microdialysis probe was produced in 1974 and used to measure the release of
dopamine during amphetamine stimulation (Ungerstedt and Pycock 1974).
Further development has lead to the modern microdialysis probe which can
be implanted into the brain and other tissues much like an electrode. The
technique has become so sophisticated that it has gained clinical use (During
and Spencer 1992).

ii. Characteristics of Microdialysis
The following list of features of microdialysis have lead its popularity
in measuring the interstitial fluid of various organs, particularly the brain
(Ungerstedt 1991):
1. Microdialysis only samples the extracellular fluid
2. Continuous sampling is possible, even over days
3. It can not only recover endogenous substances, but it can also
locally deliver pharmacological agents to manipulate the
tissues.
4. It actually removes a representative of the substance released
in the extracellular fluid, distinguishing it from
implantable bioelectrodes.
5. It produces minimal tissue injury
6. The membrane does not allow enzymes, and other large
molecules to cross, so that samples are not degraded.
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7. Various lengths of tissue can be monitored depending on the
length of the dialysis membrane.
8. Probes can be calibrated in vitro to determine the efficiency of
removing a substance from the extracellular
environment.

iii. Theory of Microdialysis
The basic principle behind microdialysis is that substances will diffuse
across the dialysis membrane according to their concentration gradient. The
microdialysis probe therefore imitates the passive function of tissue capillary.
Substances with a higher concentration in the extracellular compartment will
diffuse into the dialysate, while the reverse occurs with substances of higher
concentrations in the dialysate.
The complexity of the microdialysis technique occurs from the
interactions between the tissue, the probe, and the dialysate. With initial
insertion of the probe the tissue trauma produced and the initial influx of
substances into the probe make steady state measurements impossible. In
addition this trauma also produces a decrease in rCBF and an increase in
glucose metabolism. Therefore an initial time period must pass before a
stable tissue baseline can be established. This time period depends on the
relative size of the probe compared to the tissue studied, and in the brain is
roughly 10-20 minutes (Ungerstedt 1991). Another issue is the time over
which accurate measurements can be obtained and depends on the tissue's
reaction to the probe, the substances being measured, and the type of
instrument used.
The recovery of substances from the extracellular fluid is dependent on
the following factors (Benveniste 1989):

1. The length of diffusable membrane
2. Flow of the dialysate through the probe
3. Ability of the substance to diffuse through the extracellular
space.
4. Properties of the dialysis membrane.
Results of microdialysis are distinguished between absolute recovery
and relative recovery. Absolute recovery is the total amount of substance
recovered from the probe and will fluctuate with release of a substance by the
tissue. Relative recovery is the concentration of a substance leaving the probe
expressed as a percentage of the concentration outside the dialysis membrane
(Ungerstedt 1991). In this study the absolute recovery of microdialysis
samples was measured and the changes in concentrations expressed as the
percent of the baseline's concentration.

iv. The Microdialysis Probe
Today the method of microdialysis is so popular that manufactured
probes can be obtained, however in this study the probes were constructed. A
detailed description of the probe's construction is available in the "Materials
and Methods" section. The microdialysis probe is a simple instrument
consisting of an inlet, an outlet, and the membrane sac. The inlet delivers the
dialysate to the membrane sac. Here the dialysate equilibrates with
extracellular fluid. The fluid is continuously pumped out of the probe
through the outlet. It is then collected and analyzed.

■
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v. Diagram of Microdialysis Probe

b. Close-up view of
dialysis portion

Epoxy Plug

Dialysis _
Membrane

Polyacrylamide
Outlet

a. View of entire probe

Epoxy Plug
Polyethelyene
tubing -

83

REFERENCES
Allen PIM, and Goldman M (1987): Skin blood flow: a comparison of
transcutaneous oximetry and laser doppler flowmetry. Eur. J. Vase.
Surg. 1: 315-318.

Alvarez-Buylla R., (1951) Comparison study of the action of Dial,
Nembutal, Pentothal, chloralose and urethane on the
electrocardiogram, blood pressure, respiration and activity of the
carotid and aortic bodies. Acta Physiol, latt.-amer. 1: 309-334.
Arneric SP (1989) Basal forebrain neurons modulate cortical cerebral blood
flow: increases by nicotinic mechanisms. J. Cereb. Blood Flow Metab.
9(Supp 1):S502.
Asher P, and Nowak L (1987): Electrophysiological studies of NMDA
receptors. Trends Neurosci. 10: 284-287.
Astrup J, Heuser D, and Lassen NA (1978): Evidence against H+ and K+ as
main factors for the control of cerebral blood flow: a microelectrode
study. Elliot K, O'Connor M eds.: Cerebral vascular smooth muscle
and its control. Ciba Foundation Symposium 56. New York: Elsevier,
pp. 313-332.
Aubineau P, Pearce W, Cuevas J, and Issertial O (1989) Differential effect of
CO2 and extracellular H+ ions on cerebral arteries in vitro. J. Cereb.
Blood Flow Metab. 9(Supp 1): S507.
Aubineau P, Pearce W, Reynier-Rebuffel AM, Cuevas J, and Issertial O
(1989) Long-term sympathetic denervation increases sensitivity of
cerebral arteries to CO2 and 5-HT in vitro. J. Cereb. Blood Flow Metab.
9(Supp 1): S506.
Barres BA, Chun LLY, and Corey DP (1990): Ion channels in vertebrate glia.
Annu. Rev. Neurosci, 13: 441-474.
Bender AS, Wu PH, and Phillis JW (1981): The rapid uptake and release of
[3H] adenosine by rat cerebral cortical synaptosomes. J. Neurochem.
36(2):651-660.
Benveniste H (1989): Brain microdialysis. J. Neurochem. 52(6): 1667-1678.

84

Berntman L, Carlsson C, Hagerdal M, and Siesjo J (1978): Circulatory and
metabolic effects in the brain induced by amphetamine sulfate. Acta
Physiol. Scand. 102: 310-323.
Bijagkumar C. (1956) Blood changes with some common anesthetic agents in
dogs. Indian J. Physiol. 10: 94-99.
Bito L, Davson H, Levin E, Murray M, and Snider N (1966): The
concentrations of free amino acids and other electrolytes in
cerebrospinal fluid, in vivo dialysate of brain, and blood plasma of the
dog. J. Neurochem. 13: 1057-1067.
Bowman C.C., Kimelberg H.K. (1984) Excitatory amino acids directly
depolarize rat brain astrocytes in primary culture. Nature 311: 656-659.
Braverman IM, Keh A, and Goldminz D (1990): Correlation of laser doppler
wave patterns with underlying microvascular anatomy. J. Invest.
Dermatol. 95: 283-286.
Bredt DS, and Snyder SH (1989): Nitric oxide mediates glutamate-linked
enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci.
USA 86: 9030-9033.
Bredt DS, and Snyder SH (1992): Nitric oxide, a novel neuronal messenger.
Neuron 8: 3-11
Bredt DS, Hwang PM, and Snyder SH (1990): Localization of nitric
oxide synthase indicating a neural role for nitric oxide. Nature 347:
768-770.
Brock TA, Dennis PA, Griendling KK, Diehl TS, and Davies PF (1988):
GTPgS loading of endothelial cells stimulates phospholipase C and
uncouples ATP receptors. Am. J. Physiol. 255: C667-C673.
Brown TH, and Zador AM (1990): Hippocampus. In: The synaptic
organization of the brain (eds. Shephard GM). Oxford Univ.Press, New
York, pp. 346-388.
Buckberg GD, Luck JC, Payne B, Hoffman JIE, Archie JP, and Fixler DE (1971):
Some sources of error in measuring regional blood flow with
radioactive microspheres. J. Appl. Physiol. 31(4): 598-604.
Burnstock G (1990): Dual control of local blood flow by purines. Ann. N.Y.
Acad. Sci. 603: 31-45.

85

Bush P.A., Gonzalez N.E., Griscavage J.M., Ignarro L.J. (1992) Nitric oxide
synthase from cerebellum catalyzes the formation of equimolar
quantities of nitric oxide and citrulline from L-arginine. Biochem.
Biophys. Res. Comm. 185: 960-966.
Carter TD, Hallam TJ, and Pearson JD (1989): Protein kinase C activation alters
the sensitivity of agonist-stimulated endothelial cell prostacyclin
production to intracellular Ca+2. Biochem.J. 262: 431-437.
Caspers H, and Speckmann EJ (1972): Cerebral pC>2, pCC>2, and pH: Changes
during convulsive activity and their significance for spontaneous
arrest of seizures. Epilepsia 13: 699-725.
Chien S (1985): Cerebral blood flow and metabolism. In: Principles of
Neuroscience (Kandel ER and Schwartz JH eds.). Elsevier, New York,
pp. 845-848.
Cobb S, and Talbott JH (1927): Studies in cerebral circulation. II. A
quantitative study of cerebral capillaries. Trans. Assoc. Am. Physcians
42: 255-262.
Cotman CW, and Iversen LL (1987): Excitatory amino acids in the
brain-Focus on NMDA receptors. Trends Neurosci. 7: 263-265.
Cotman CW, Monaghan DT, Ottersen OP, and Storm-Mathisen J (1987):
Anatomical organization of excitatory amino acid receptors and their
pathways. Trends Neurosci. 10: 273-279.
Csillik B, Jancse G, Toth L, Kozma M, Kalman G, and Karcsu S (1971):
Adrenergic innervation of hypothalmic blood vessels, a contribution to
the problem of central thermodetectors. Act. Anat. 80: 142-151.
Dawson TM, Dawson VL, and Snyder SH (1992): A novel neuronal messenger
molecule in brain: the free radical, nitric oxide. Ann. Neurol. 32: 297311.
Dawson VL, Dawson TM, London ED, Bredt DS, and Snyder SH (1991): Nitric
oxide mediates glutamate neurotoxicity in primary cortical cultures.
Proc. Natl. Acad. Sci. USA 88: 6368-6371.
Delgado JMR, DeFeudis FV, Roth RH, Ryugo DK, and Mitruka BM (1972):
Dialytrode for long term intracerebral perfusion in awake monkeys.
Archs int. Pharmacodyn. 198:9-21.

86

Devine D.P., Leone P., Wise R.A. (1993) Striatal tissue preparation facilitates
early sampling in microdialysis and reveals an index of neuronal
damage. J. Neurochemistry. 61: 1246-1254.
Dimitriadou V, Aubineau P, Taxi J, and Seylaz J (1989) Sympathectomy delays
muscle cell differentiation in growing cerebral arterioles. J. Cereb.
Blood Flow Metab. 9(Supp 1): S391.
Dirnagl U, Kaplan B, Jacewicz M, and Pulsinelli W (1989): Continuous
measurement of cerebral cortical blood flow by laser-doppler flowmetry
in a rat stroke model. J. Cereb. Blood Flow Metabol. 9: 589-596.
Dodd PR, and Bradford HF (1974): Release of amino acids from the
chronically-superfused mammalian cerebral cortex. J. Neurochem. 23:
289-292.
Dora E, Koller A, and Kovach AGB (1980): Effect of topical adenosine
deaminase treatment on the functional hyperemic and hypoxic
reponses of cerebrocortical microcirculation. J. Cereb. Blood Flow
Metabol. 4: 447-457.
Drayer BP, Wolfson Jr., SK, Reinmuth OM, Dujovny M, Boehnke M, and
Cook EE (1978): Xenon enhanced CT for analysis of cerebral integrity,
perfusion, and blood flow. Stroke 9(2): 123-130.
Dumke PR, and Schmidt CF (1943): Quantitative measurements of cerebral
blood flow in the macacque monkey. Am. J. Physiol. 138: 421-431.
Dunwiddie TV (1980): Endogenously released adenosine regulates
excitability in the in vitro hippocampus. Eplilepsia 21: 541-548.
During M.J., Spencer D.D. (1993) Extracellular hippocampal glutamate and
spontaneous seizure in the conscious human brain. Lancet 341: 16071610.
During M.J., Spencer D.D., (1992) Adenosine: a potential mediator of seizure
arrest and postictal refractoriness. Ann Neurol. 32: 618-624.
Durst F, Melling A, and Whitelaw JH (1976): Principles and practice of laser
doppler anemometry. Academic Press, London, New York, and San
Fransicisco.
Edvinsson L (1985): Functional role of perivascular peptides in the control of
cerebral circulation. Trends Neurosci. 8: 126-131.

87

Edvinsson L, and Fredholm BB (1983): Characterization of adenosine
receptors in isolated cerebral arteries of cat. Eur. J. Pharmac. 80: 631-637.
Edvinsson L, Degueurce A, and Duverger DD (1983): Central serotinergic
nerves project to the pial vessels of the brain. Nature 306: 55-57.
Edvinsson L, Hara H, and Uddman R (1989) The origin of perivascular
peptidergic nerve fibers as shown by retrograde tracing and
immunocytochemistry. J. Cereb. Blood Flow Metab. 9(Supp 1): S484.
Edvinsson L, Nielsen KC, Owman C, and Sporrong B (1972): Cholinergic
mechanisms in pial vessels. Histology, electron microscopy, and
pharmacology. Z Zellforsch Anat. 134: 311-325.
Einav S, Berman F1J, Fuhro RL, Digovanni PR, Fine S, and Fridman JD (1975):
Measurement of velocity profiles of red blood cells in the
microcirulation by laser doppler anemometry (LDA). Biorheology 12:
207-210.
Eyre JA, Essex TJH, Flecknell PA, Bartholomew PH, and Sinclair JI (1988): A
comparison of measurements of cerebral blood flow in the rabbit using
laser doppler spectroscopy and radionuclide labelled microspheres.
Clin. Phys. Physiol. Meas. 9(1): 65-74.
Faraci F.M., and Breese K.R. (1993) Nitric oxide mediates vasodilatation in
response to activation of N-methyl-D-aspartate receptors in brain. Cir.
Res. 72:476-480.
Florey HW (1925): Microscopical observations of the circulation of the blood
in the cerebral cortex. Brain 48: 43-64.
Forestermann U, Schmidt HH, Pollock JS, Sheng H, Mitchell JA, Warner TD,
Nakane M, and Murad F (1991): Isoforms of nitric oxide synthase.
Characterization and purification from different cell types. Biochem.
Pharmacol. 42: 1849-1857.
Forsberg EJ, Feuerstein G, Shohami E, and Pollard HB (1987): Adenosine
triphosphate stimulates inositol phospholipid metabolism and
prostacyclin formation in adrenal medullary endothelial cells by means
of P2-purinergic receptors. Proc. Natl. Acad. Sci. 84: 5630-5634.
Fox PT, and Raichle ME (1986): Focal physiological uncoupling of cerebral
blood flow and oxidative metabolism during somatosensory
stimulation in human subjects. Proc. Natl. Acad. Sci. (USA) 83: 11401144.

88

Fredholm BB, Jonzon B, Lindgren E, and Lindstrom K (1982):
Adenosine recepotrs mediating cyclic AMP production in the rat
hippocampus. J. Neurochem. 39: 165-175.
Freygang WH, and Sokoloff L (1958): Quantitative measurement of
regional circulation in the central nervous system by the use of
radioactive inert gas. Adv. Biol. Med. Phys. 6: 263-279.
Garthwaite J, Charles SL, and Chess-Williams (1988): Endothelium-derived
relaxing factor release on activation of NMDA receptors suggests role as
intercellular messenger in the brain. Nature 336(24): 385-387.
Gibbons IL, Brayden JE, and Brevan JA (1984): Distribution and origin of VIPimmuno-reactive nerves in the cephalic circulation of the cat. Peptides
5: 209-212.
Gibbs FA (1933): A thermoelectric blood flow recorder in the form of a needle.
Proc. Soc. Exptl. Biol. Med. 31: 141-146.
Goadsby PJ (1989) Activation of the facial nerve dilator pathway increases
cerebral blood flow independent of cerebral glucose utilization in the
anesthetized cat. J. Cereb. Blood Flow Metab. 9(Supp 1): S370.
Gold ME, Wood KS, Byrns RE, Fukuto J, and Ignarro JL (1990): NG-Methyl-Larginine causes endothelium-dependent contraction and inhibition of
cyclic GMP formation in artery and vein. Proc. Natl. Acad. Sci. USA 87:
4430-4434.
Goldman SA, Pulsinelli WA, Clarke WY, Kraig RP, and Plum F (1989):
The effects of extracellular acidosis on neurons and glia in vitro. J.
Cereb. Blood Flow Metabol. 9: 471-477.
Good WF, Gur D, Shabason L, Wolfson Jr., SK, Yonas H, Latchaw RE,
Herbert DL, and Kennedy WH (1982): Errors associated with single-scan
determinations of regional cerebral blood flow by xenon enhanced CT.
Phys. Med. Biol. 27(4): 531-537.
Gotoh F, Tazaki Y, and Meyer JS (1961): Transport of gases through the brain
and their extravascular vasomotor action. Expt. Neurol. 4: 48-58.
Greenberg J, Hand P, Sylvestro A, and Reivich M (1979) Localized metabolicflow couple during functional activity. Acta Neurol. Scand. 60(Supp
72): 12-13.
Guoyao WU, and Brosnan JT (1992): Macrophages can convert citrulline into
arginine. Biochem. J. 281: 45-48.

89

Guyton AC (1986): Local control of blood flow by the tissues, and nervous and
humoral regulation. In: Textbook of Medical Physiology. (Dana
Dreibelbis ed.) W.B. Saunders Co. pp. 234-235.
Guyton AC (1986): Textbook of Medical Physiology. W.B. Saunders Co.,
Philadelphia, pp. 234-235.
Haberl RL, Heizer ML, Marmarou A, and Ellis EF (1989): Laser-doppler
assessment of brain microcirculation: effect of systemic alterations.
Am. J. Physiol. 256(Heart Circ. Physiol. 25): H1247-H1254.
Haining JL, Turner MD, and Pantall RM (1968): Measurement of local
cerebral blood flow in the unanesthetized rat using a hydrogen
clearance method. Cir Res. 23: 313-324.
Haley JE, Wilcox GL, and Chapman PF (1992): The role of nitric oxide in
hippocampal long-term potentiation. Neuron 8: 211-216.
Halsey JH, Capra NF, and McFarland RS (1977): Use of hydrogen for
measurement of regional cerebral blood flow. Stroke 8: 351-357.
Hardebo JE, Kahstrom J, and Owman C (1987): Pl-and P2-purine recpetors in
brain circulation. Eur. J. Pharmacol. 144: 343-352.
Harper AM, and MacKenzie ET (1977): Effects of 5-hydroxytryptamine on pial
arteriolar calibre in anesthetized cats. J. Physiol. (London) 271: 735-736.
Hartman BK, Zide D, and Undenfriend S (1972): The use of dopaminehydroxylase as a marker for the central noradrenergic nervous system
in rat brain. Proc. Natl. Acad. Sci. (USA) 69: 2722-2726.
Hill L, and Macleod JJR (1900): Further enquiry into the supposed existence of
cerebral vaso-motor nerves. J. Physiol. (London) 26: 394-404.
Holloway GA Jr. (1980): Cutaneous blood flow responses to injection trauma
measured by laser doppler veiocimetry. J. Invest. Derm. 74: 1-4.
Holloway GA Jr. and Watkins DW (1977): Laser doppler measurement of
cutaneous blood flow. J. Invest. Dermatol. 69: 306-309.
Holti G and Mitchell KW (1978): Estimation of the nutrient skin blood flow
using a segmented thermal clearence probe. Clin. Exp. Dermatol. 3:
189-198.
Iadecola C (1993): Regulation of the cerebral microcirculation during neural
activity: is nitric oxide the missing link. TINS 16(6): 206-214.

90

Iadecola C, Arneric S, Baker H, Tucker L, and Reis D (1987): Role of local
neurons in the cerebrocortical vasodilation elicited from cerebellum.
Am. J. Physiol. 252(Regulatory Integrative Comp. Physiol. 21): R10821091.
Iadecola C, Zhang F, and Xu X (1993): Role of nitric oxide synthase -containing
nerves in cerebrovasodilatation elicited from the cerebellum. Am. J.
Physiol. 264: R738-R746.
Ibayashi S, Ngai AC, Howard HI, MA, Meno JR, and Winn HR (1991): Lack of
sympathetic and cholinergic influences on cerebral vasodilatation by
sciatic nerve stimulation in the rat. J. Cereb. Blood Flow Metabol. 11:
678-683.
Ibayashi S, Ngai AC, Meno JR, and Winn HR (1991): Effects of topical
adenosine analogs and forskoiin on rat pial arterioles in vivo. J.
Cereb.Blood Flow Metabol. 11: 72-76.
Ingvar DH, and Lassen NA (1962): Regional blood flow of the cerebral cortex
determined by Krypton85. Acta Physiol. Scand. 54: 325-338.
Ingvar DH, Lubbers DW, and Siesjo BK (1962): Normal and epileptic EEG
patterns related tocortical oxygen tension in the cat. Acta Physiol.
Scand. 55: 210-224.
Johnson J., Taylor W., Shepherd A., Park M. (1984) Laser-doppler
measurement of skin flow: comparison with plethysmography J Appl
Physiol: Respirat Environ Exercise Physiol. 56; 798-803.
Jonzon B, and Fredholm BB (1985): Release of purines, noradrenaline, and
GABA from rat hippocampal slices by field stimulation. J. Neurochem.
44(1): 217-224.
Kajiya F, Hoki N, Tomonaga G, and Nishihara H (1981): A laser doppler
velocimeter using an optical fiber and its application to local velocity
measurement in the coronary artery. Experientia 37: 1171-1173.
Keller JT, Beduk A, and Saunders MC (1985): Origin of fibers innervating the
basilar artery of the cat. Neurosci. Lett. 58: 263-268.
Kety SS and Schmidt CF (1946): The effects of active and passive
hyperventilation of cerebral blood flow, cerebral oxygen consumption,
cardiac output, and blood pressure of normal young men. J. Clin.
Invest. 25: 107-119.

91

Kety SS, and Schmidt CF (1945): The determination of cerebral blood flow in
man by the use of nitrous oxide in low concetrations. Am. J. Physiol.
143: 53-66.
Kety SS, and Schmidt CF (1948): The effects of altered arterial tensions of
carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen
consumption of normal young men. J. Clin. Invest. 27: 484-492.
Kety SS, and Schmidt CF (1948): The nitrous oxide method for the
quantitative determination of cerebral blood flow in man: Theory,
procedure, and normal values. J. Cline. Invest. 27: 476-483.
Kety SS, Shenkin HA, and Schmidt CF (1948): The effects of increased
intracranial pressure on cerebral circulatory functions in man. J. Clin.
Invest. 27: 493-499.
Kiedrowski L, Erminio C, and Wroblewski JT (1992): Glutamate receptor
agonists stimulate nitric oxide synthase in primary cultures of
cerebellar granule cells. J. Neurochem. 58: 335-341.
Ko KR, Ngai AC, and Winn HR (1990): Role of adenosine in regulation of
regional cerebral blood flow in sensory cortex. Am. J. Physiol. 259(6 pt
2): H1703-H1708.
Kogure K, Scheinberg P, and Reinmuth OM (1970): Mechanisms of cerebral
vasodilation in hypoxia. J. Appl. Physiol. 29: 223-229.
Koketsu N, Moskowitz MA, Kontos HA, Yokota M, and Shimizu T (1992):
Chronic parasympathetic sectioning decreases regional cerebral blood
flow during hemorhagic hypotension and increases infarct size after
middle cerebra artery occlusion in spntaneously hypertensive rats. J.
Cereb. Blood Flow Metabol. 12: 613-620.
Kontos HA, Raper AJ, and Patterson JL (1977): Analysis of vasoactivity of local
pH, pC02, and bicarbonate on pial vessels. Stroke 8: 358-360.
Kraig RP and lacecola C (1989) Reduction of astroglial K+ accumualtion
enhances elevation in cerebral blood flow from neuronal activation. J.
Cereb. Blood Flow Metab. 9(Supp 1): S207.
Kuschinsky W, Wahl M, Bosse O, and Thuraw K (1972): Perivascular
potassium and pH as determinants of local pial arterial diameter in
cats. Cir. Res. 31: 240-247.

92

Lacombe P, Meric P, and Seylaz Y (1980): Validity of cerebral blood flow
measurements obtained with quantitative tracer techniques. Brain
Res. Rev. 2: 105-169.
LaManna JC, Harik SI, Light AI, and Rosenthal M (1981): Norepinephrine
depletion alters cerebral oxidative metabolism in the active state. Brain
Res. 204: 87-101.
Lassen NA (1966): Luxury-perfusion syndrome and its possible
relations to acute metabolic acidosis localized within the brain. Lancet
ii: 1113-1115.
Lassen NA, and Munck O (1955): The cerebral blood flow in man determined
by the use of radioactive krypton. Acta Physiol. Scand. 33: 30.
Leniger-Follert E (1984): Mechanisms of regulation of cerebral microflow
during bicuculline induced seizures in anaesthetized cats. J. Cereb.
Blood Flow Metabol. 4: 150-165.
Leniger-Follert E, and Lubbers DW (1976): Behavior of microflow and local
p02 of the brain cortex during and after direct electrical stimulation.
Pflugers Arch. 366: 39-44.
Leone AM, Palmer RMJ, Knowles RG, Francis PL, Ashton DS, and Moncada S
(1991): Constitutive and inducible nitric oxide synthases incorporate
molecular oxygen into both nitric oxide and citrulline. J. Biol. Chem.
266(35): 23790-23795.
Lindauer U., Dirnagl U., Villringer A. (1993) Characterization of the cerebral
blood flow response to somatosensory stimulation with detailed
description of the model and the influence of anesthetics. Am J
Physiol 264: H1223-H1228.
Lou HC, Edvinsson L, and MacKenzie ET (1987): The concept of coupling
blood flow to brain function: revision required? Ann. Neurol. 22: 289297.
MacKenzie ET and Scatton B (1987): Cerebral circulatory and metabolic effects.
CRC Crit. Rev. clin. Neurobiol. 2: 357-419.
Maiman TH (1960): Stimulated optical radiation in ruby. Nature 187: 493-494.
Malinski T., Bailey F., Zhang Z.G., Chopp M. (1993) Nitric oxide measured by a
porphyrinic microsensor in rat brain after transient middle cerebral
artery occlusion. J Cerebral Blood Flow Metabolism 13: 355-358.

93

Marsden CA, Brazell MP, and Maidment NT (1984): An introduction to in
vivo electrochemistry. In: Measurements of neurotransmitter release
in vivo, pp. 127-153. ed. CA Marsden. Wiley: New York.
Morii S, Ngai AC, and Winn HR (1986): Reactivity of rat pial arterioles and
venules to adenosine and carbon dioxide: with detailed description of
the closed cranial window technique in rats. J. Cereb. Blood Flow
Metabol. 6: 34-41.
Morris JH and Phil D (1989): The Nervous System. In Robbins Pathologic
Basis of Disease, (eds. Cotran RS, Kumar V, and Robbins SL) W.B.
Saunders Co., Philadelphia, pp. 1389, 1402-1403.
Nakai M, Iadecola C, and Reis D (1982): Global cerebral vasodilation by
stimulation of rat fastigial nucleus. Am. J. Physiol. 243(Heart Circ.
Physiol 12): H226-H235.
Ngai AC, and Winn HR (1993): Effects of adenosine and its analogues
islolated intra-cerebral arterioles-extraluminal and intraluminal
application. Cir. Res. 73: 448-457.
Ngai AC, Ko KR, and Winn HR (1988): Effect of sciatic nerve stimulation on
pial arterioles in rats. Am. J. Physiol. 254:H133-H139.
Nilsson B, Rechncrona S, and Siesjo BK (1978): Coupling of cerebral
metabolism and blood flow in epileptic seizures, hypoxia and
hyperglycemia. In Elliot K, O'Connor M (eds.): Cerebral vascular
smooth muscle and its control, Ciba Foundation symposium 56. New
York: Elsevier, pp. 199-214.
Niwa K, Lindauer U, Villringer A, and Dirnagl U (1993): Coupling of cerebral
blood flow to neuronal activation: role of adenosine and nitric oxide.
Neurosci. Abstracts 503.1.
Northington FJ, Matherne GP, Coleman SD, and Berne RM (1992): Sciatic
nerve stimualtion does not increase endogenous adenosineproduction
in sensory-motorcortex. J.Cereb.Blood Flow Metabol. 12:835-843.
Nozaki K, Moskowitz MA, Maynard KI, Koketsu N, Dawson TM, Bredt DS,
and Snyder SH (1993): Possible origins and distribution of
immunoreactive nitric oxide synthase-containing nerve fibers in
cerebral arteries. J. Cereb. Blood Flow Metabol. 13: 70-79.
Nylin G, and Blomer H (1955): Studies on distribution of cerebral blood flow
with thorium b-labeled erythrocytes. Cir. Res. 3: 79-85.

94

Oeberg PA, Tenland T, and Nilsson GE (1984): Laser-doppler flowmetry-a
noninvasive and continuous method for blood flow evaluation in
microvascular studies. Acta Med. Scand. (suppl) 687: 17-24.
Ogawa S, Tank DW, Menon R, Ellermann JM, Kim SG, Merkle H, and
Ugurbil K (1992): Intrinsic signal changes accompanying sensory
stimulation: Functional brain mapping with magnetic resonance
imaging. Proc. Natl. Acad. Sci. USA 89: 5951-5955.
Okada D (1992): Two pathways of cyclic GMP production through glutamate
receptor-mediated nitric oxide synthesis. J. Neurochem. 59: 1203-1210.
Olesen J (1971): Contralateral focal increase of cerebral blood flow in man
during arm work. Brain 94: 635-646.
Olsson P. (1986) A comparison between the Xe washout and laser doppler
techniques for estimation of nasal mucosal blood flow in humans.
Acta Otolaryngol (Stockh) . 102: 106-112.
Olsson RA, and Pearson JD (1990): Cardiovascular purinoceptors. Physiol.
Rev. 70: 761-845.
Owman C, Hardebo JE, Kahrstrom J, and Suzuki N (1989) Innervation of
galanin-positive nerves in the cerebral blood vessels. J. Cereb. Blood
Flow Metab. 9(Supp 1): S676.
Palmer RMJ, Ferrige AG, and Moncada S (1987): Nitric oxide release accounts
for the biological activity of endothelium-derived relaxing factor.
Nature 327: 524-526.
Paulson OB, and Newman EA (1987): Does the release of potassium from
astrocyte endfeet regulate cerebral blood flow. Science 237: 896-898.
Paxinos G and Watson C (1986): The rat brain in stereotaxic coordinates.
Academic Press Inc. Orlando, FL.
Pelleg A, and Burnstock G (1990): Physiological importance of ATP released
from nerve terminals and its degradation to adenosine in humans.
Cir. 82: 2269-2272.
Phillippu A (1984): Use of push-pull cannulae to determine the release of
endogenous neurotransmitters in distinct brain areas of anesthetized
and freely moving animals. In: Measurements of neurotransmitter
release in vivo (Marsden CA ed.) pp. 3-39. Wiley and Sons: New York.

95

Phillis JW, and Wu PH (1981): The role of adenosine and its nucleotides in
central synaptic transmission. Prog. Neurobiol. 16: 187-239.
Phillis JW, DeLong RE, and Towner JK (1985): Adenosine deaminase
inhibitors enhance cerebral anoxic hyperemia in the rat. J. Cereb. Blood
Flow Metabol. 5: 295-299.
Plum F (1983): What causes infarction in ischemic brain?: The Robert
Wartenberg Lecture Neurol. 33: 222-233.
Plum F, Posner JB, and Troy B (1968): Cerebral metabolic and circulatory
reponses to induced convulsions in animals. Arch. Neurol. 18: 1-13.
Raichle ME, Grubb RL, and Gado MH (1976): Correlation between regional
cerebral blood flow and oxidative metabolism. Arch. Neurol. 33: 523526.
Rapela CE, and Green HD (1964): Autoregulation of canine cerebral blood
flow. Cir. Res.l4(Supp 1): 1205-1211.

Reinhard JF, Leibmann JE, Schlosberg AJ, and Moskowitz MA (1979):
Serotonin neurons project to small blood vessels in the brain. Science
206: 85-87.
Rennels ML, and Nelson E (1975): Capillary innervation in the mammalian
central nervous system: an electron microscope demonstration. Am. J.
Anat. 144: 233-241.
Richardson PJ, Brown SJ, Bailyes EM, and Luzio JP (1987): Ectoenzymes
control adenosine modulation of immunoisolated cholinergic
synapses. Nature 327: 232-234.
Riva C., Ross B., Benedek G.B. (1972) Laser doppler measurements of blood
flow in capillary tubes and retinal arteries. J. Investigative Derm. 11:
936-944.
Robinson T.E. and Justice J.B., eds (1991) Techniques in the Behavioral and
Neural Sciences, Vol. 7: Microdialysis in the Neurosciences. Elsevier,
New York.
Rogers N.E., Ignarro L.J. (1992) Constitutive nitric oxide synthase from
cerebellum is reversibly inhibited by nitric oxide formed from Larginine. Biochem and Biophy Res Comm 189: 242-249.

96

Roland PE, Larsen B, Lassen NA, and Skinhoj E (1980): Supplemnetary motor
area and other cortical areas in organization of voluntary movements
in man. J. Neurophysiol. 43: 118-136.
Roth JA, Greenfield AJ, Kaihara S, and Wagner Jr., HN (1970): Total and
regional cerebral blood flow in unanesthetized dogs. Am. J. Physiol.
219(1): 96-101.
Roy CW and Sherrington CS (1890): On the regulation of the blood supply of
the brain. J. Physiol. 11: 85-108.
Rubio R, Berne RM, Bockman EL, and Curnisk RR (1975): Relationship
between adenosine concentration and oxygen supply in rat brain. Am
J. Physiol. 228: 1896-1902.
Sakas DE, Moskowitz MA, Buzzi MG, Wei EP, Kontos HA, and Kano M
(1989) Trigeminovascular fibers increase blood flow in cortical grey
matter by axon reflex-like mechanisms. J. Cereb. Blood Flow Metab.
9(Supp 1): S31.
Sakurada O, Kennedy C, Jehle J, Brown JD, Carbin GL, and Sokoloff L (1978):
Measurement of local cerebral blood flow with iodo[^^C]antipyrine.
Am. J. Physiol. 234:H59-H66.
Schmidt CF (1950): The cerebral circulation in health and disease. Springfield,
Illinois.eds. CC Thomas.
Schmidt HHHW (1992): NO-, CO and -OH-endogenous soluble guanylyl
cyclase-activating factors. Fed. Eur. Biochem. Soc. 307(1): 102-107.
Schottler F, Collins J, Sagher O, Okonkwo D, Martin A, Kassell NF, and
Lee KS (1993): Neurovascular interactions of nitric oxide synthase¬
positive neurons in rat hippocampus. Neurosci. Abstracts 503.6.
Shinhoj E (1966): Regulation of cerebral blood flow as a single function of the
interstial pH in the brain. Acta Physiol. Scand. 42: 604-607.
Shulman RG, Blamire AM, Rothman DL, and McCarthy G (1993): Nuclear
magnetic resonance imaging and spectroscopy of human brain
function. Proc. Natl. Acad. Sci. 90: 3127-3133.
Silver IA (1978): Cellular microenvironment in relation to local blood flow.
In Elliot K, O'Connor M (eds.): Cerebral vascular smooth muscle and
its control, Ciba Foundation Symposium 56. New York: Elsevier, pp.
49-61.

97

Silverberg GD (1989) Extracellular pH change alters calcium channel
conductance in cerebral arterioles of the rat: a mechanism of
metabolic autoregulation. J. Cereb. Blood Flow Metab. 9(Supp 1):
S396.
Skarphedinsson JO, Harding H, and Thoren P (1988): Repeated measurements
of cerebral blood flow in rats. Comparisons between the hydrogen
clearance method and laser doppler flowmetry. Acta Physiol. Scand.
134:133-142.
Snyder SH and Bredt DS (1992): Biological roles of nitric oxide. Sci. Am.
266(5): 68-77.
Sokoloff L (1961): Local cerebral circulation at rest and during altered cerebral
activity induced by anesthesia or visual stimualtion. Kety SS, and
Elkes J eds. The regional chemistry, physiology, and pharmacology of
the nervous system. Oxford: Pergamon Press Ltd. p. 107-117.
Sokoloff L (1977): Relation between physiological function and energy
metabolism in the central nervous system. J. Neurochem. 29: 13-26.
Sokoloff L (1981): Relationship among local functional activity, energy
metabolism, and blood flow in the central nervous system. Fred. Proc.
40: 2311-2316.
Stern MD (1975): In vivo evaluation of microcirculation by coherent light
scattering. Nature (London) 254: 56-58.
Stuehr DJ, and Nathan CF (1989): Nitric oxide. A macrophage product
responsible for cytostasis and respiratory inhibition in tumor target
cells J. Exp. Med. 169:1543-1555.
Suzuki N, Hardebo JE, and Owman C (1989) Origins and pathways of SP- and
CGRP-positive nerves in cerebral blood vessels. J. Cereb. Blood Flow
Metab. 9(Supp 1): S678.
Swanson LW, Connelly MA, and Hartman BK (1977): Ultrastructure
evidence for central monaminergic innervation of blood vessels in the
paraventricular nucleus of the hypothalamus. Brain Res. 136: 166-173.
Tanaka T, Riva C, and Ben-Sira I (1974): Blood velocity measurements in
human retinal vessels. Science 186: 830-831.
Tenland T (1982): On laser doppler flowmetery. Methods and microvascular
applications. Thesis, University of Linkoping, Sweden.

98

Thomas RC (1978): Ion-sensitive intracellular microelectrodes. Academic
Press: New York
Torregrosa G, Salom JB, Miranda FJ, Alabadi JA, Alvarez C, and Alborch E
(1990): Adenosine A2 receptors mediate cerebra vasodilation inthe
conscious goat. Blood Vessels 27: 24-27.
Ukei M., Mies G., Hossmann K.A. (1992) Effect of alpha-chloralose,
halothane, pentobarbital, and nitrous oxide anesthesia on metabolic
coupling in somatosensory cortes of rat. Acta Anaesthesiol Scand 36:
318-322.
Ungerstedt U (1984): Measurements of neurotransmitter release by
intracranial dilaysis. In: Measurement of neurotransmitter release in
vivo, pp. 81-105. ed. CA Marsden. Wiley: New York.
Ungerstedt U (1991): Microdialysis-principles and applications for studies in
animals and man. J. Intern. Med. 230: 365-373.
Ungerstedt U and Pycock C (1974): Functional correlates of dopamine
neurotransmission. Bull. Schweiz Akad. Med. Wiss. 1278: 1-13.
Wahl M, and Kuschinsky W (1977): Dependency of dilatory action of
adenosine on the perivascular H+ and K+ at pial arteries of cats. Acta
Neurol. Scand. (suppl): 56: 218-219.
Watkins D and Holloway GA (1978): An instrument to measure cutaneous
blood flow using the Doppler shift of laser light. IEEE TRans Biomed.
Eng. BME-25: 28-33.
White KA, and Marietta MA (1992): Nitric oxide synthase is a cytochrome
P-450 type hemoprotein. Biochem. 31(29): 6627-6631.
White T.D., Constance C.G., Hoehn K. (1993) Extracellular adenosine,
formed during low level NMDA receptor activation, provides an
inhibitory threshold against further NMDA receptor-mediated
neurotransmission in the cortex. Drug Dev Res 28: 406-409.
Winn HR, Moni S, and Berne RM (1985): The role of adenosine in
autoregulation of cerebral blood flow. Ann Biomed. Eng. 13: 321-328.
Winn HR, Welsh JE, Rubio R, and Berne RM (1980): Changes in brain
adenosine during bicuculiine inducded seizures. Effects of hypoxia and
altered systemic blood pressure. Cir. Res. 47: 568-577.

99
Wolff HG (1936): The Cerebral Circulation. Physiol. Rev. 16: 545-596.
Wyllie D.J.A., Mathie A., Symonds C.J., et al. (1991) Activation of glutamate
receptors and glutamate uptake in identified macroglial cells in rat
cerebellar cultures. J. Physiol (Lond.) 91: 235-250.
Yaksh TL, Wong JY, Go VLW, and Harty GJ (1987): Cortical vasodilatation
produced by vasoactive intestinal polypeptide (VIP) and by
physiological stimuli in the cat. J. Cereb. Blood Flow Metabol. 7: 315326.
Zetterstrom T., Vernet L., Ungerstedt U., Tossman U., Jonzon B.,
Fredholm B.B. (1982) Purine levels in the intact rat brain. Studies with
an implanted perfused hollow fibre. Neurosci. Lett. 29: 111-115.

for the purpose of individual scholarly consultation or reference
is hereby granted by the author.

This permission is not to be

interpreted as affecting publication of this work or otherwise
placing it in the public domain, and the author reserves all rights
of ownership guaranteed under common law protection of unpublished
manuscripts.

Signature of Author

/

Date

/

